EurekaMag PDF full texts Chapter 11,674

Alpert, E.; Altman, H.; Totary, H.; Gruzman, A.; Barnea, D.; Barash, V.; Sasson, S. 2004: 4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells. Biochemical Pharmacology 67(10): 1985-1995

Fujita, H.; Okimura, Y.; Utsumi, T.; Kitamura, S.; Kuroki, H.; Otsuki, T.; Sasaki, J.; Kashiwagi, A.; Utsumi, K. 2006: 4-hydroxy-3,5,3',4'-tetrachlorobiphenyl induced membrane permeability transition in isolated rat liver mitochondria. Journal of Clinical Biochemistry and Nutrition 38(3): 167-175

Hayakawa, I.; Shioya, R.; Agatsuma, T.; Furukawa, H.; Naruto, S.; Sugano, Y. 2004: 4-hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as potent anti-tumor agents. Bioorganic and Medicinal Chemistry Letters 14(2): 455-458, 19 January

You, S-Hee.; Gauger, K.J.; Bansal, R.; Zoeller, R.Thomas. 2006: 4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells. Molecular and Cellular Endocrinology 257-258: 26-34

Ten Brinke, A.; Dekkers, D.W.C.; Notten, S.M.; Karsten, M.L.; de Groot, E.R.; Aarden, L.A. 2005: 4-Hydroxy-oxyphenbutazone is a potent inhibitor of cytokine production. European Cytokine Network 16(2): 144-151

Shimada, A.; Inokuchi, T.; Kusano, M.; Takeuchi, S.; Inoue, R.; Tanita, M.; Fujioka, S.; Kimura, Y. 2004: 4-hydroxykigelin and 6-demethylkigelin, root growth promoters, produced by Aspergillus terreus. Zeitschrift für Naturforschung. C Journal of Biosciences 59(3-4): 218-222

Barrera, G.; Pizzimenti, S.; Dianzani, M.U. 2004: 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radical Biology and Medicine 37(5): 597-606

Smith, J.L.; Xiong, S.; Lovell, M.A. 2005: 4-Hydroxynonenal disrupts zinc export in primary rat cortical cells. Neurotoxicology 27(1): 1-5

Pizzimenti, S.; Briatore, F.; Laurora, S.; Toaldo, C.; Maggio, M.; De Grandi, M.; Meaglia, L.; Menegatti, E.; Giglioni, B.; Dianzani, M.U.; Barrera, G. 2006: 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radical Biology and Medicine 40(9): 1578-1591

Kimura, H.; Mukaida, M.; Kuwabara, K.; Ito, T.; Hashino, K.; Uchida, K.; Matsumoto, K.; Yoshida, K-ichi. 2006: 4-Hydroxynonenal modifies IgA in rat intestine after lipopolysaccharide injection. Free Radical Biology and Medicine 41(6): 973-978

Carbone, D.L.; Doorn, J.A.; Petersen, D.R. 2004: 4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase. Free Radical Biology and Medicine 37(9): 1430-1439

Castello, L.; Marengo, B.; Nitti, M.; Froio, T.; Domenicotti, C.; Biasi, F.; Leonarduzzi, G.; Pronzato, M.A.; Marinari, U.M.; Poli, G.; Chiarpotto, E. 2005: 4-Hydroxynonenal signalling to apoptosis in isolated rat hepatocytes: the role of PKC-delta. Biochimica et Biophysica Acta 1737(2-3): 83-93

Yu, L.; Blaser, M.; Andrei, P.I.; Pierik, A.J.; Selmer, T. 2006: 4-Hydroxyphenylacetate decarboxylases: properties of a novel subclass of glycyl radical enzyme systems. Biochemistry 45(31): 9584-9592

Borowski, T.; Bassan, A.; Siegbahn, P.E.M. 2004: 4-Hydroxyphenylpyruvate dioxygenase: a hybrid density functional study of the catalytic reaction mechanism. Biochemistry 43(38): 12331-12342

Kanojia, D.; Vaidya, M.M. 2006: 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncology 42(7): 655-667

Miao, Z-Hong.; Rao, V.Ashutosh.; Agama, K.; Antony, S.; Kohn, K.W.; Pommier, Y. 2006: 4-nitroquinoline-1-oxide induces the formation of cellular topoisomerase I-DNA cleavage complexes. Cancer Research 66(13): 6540-6545

Johnson, W.H.; Wang, S.C.; Stanley, T.M.; Czerwinski, R.M.; Almrud, J.J.; Poelarends, G.J.; Murzin, A.G.; Whitman, C.P. 2004: 4-Oxalocrotonate tautomerase, its homologue YwhB, and active vinylpyruvate hydratase: synthesis and evaluation of 2-fluoro substrate analogues. Biochemistry 43(32): 10490-10501

Villani, M.Grazia.; Appierto, V.; Cavadini, E.; Bettiga, A.; Prinetti, A.; Clagett-Dame, M.; Curley, R.W.; Formelli, F. 2006: 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Cancer Research 66(6): 3238-3247

Palmer, B.D.; Thompson, A.M.; Booth, R.John.; Dobrusin, E.M.; Kraker, A.J.; Lee, H.H.; Lunney, E.A.; Mitchell, L.H.; Ortwine, D.F.; Smaill, J.B.; Swan, L.M.; Denny, W.A. 2006: 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution. Journal of Medicinal Chemistry 49(16): 4896-4911

Kroll, T.M.; Bommiasamy, H.; Boissy, R.E.; Hernandez, C.; Nickoloff, B.J.; Mestril, R.; Caroline Le Poole, I. 2005: 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. Journal of Investigative Dermatology 124(4): 798-806

Schröder, F.H.; Raaijmakers, Ré.; Postma, R.; van der Kwast, T.H.; Roobol, M.J. 2005: 4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Journal of Urology 174(2): 489-94; Discussion 493-4

Fukatsu, K.; Bannai, H.; Inoue, T.; Mikoshiba, K. 2006: 4.1N binding regions of inositol 1,4,5-trisphosphate receptor type 1. Biochemical and Biophysical Research Communications 342(2): 573-576

Dueker, G.L.; Modi, A.; Needham, A. 2003: 4.5-Month-old infants' learning, retention and use of object boundary information. Infant Behavior and Development 26(4): 588-605

Katzur, J.; Boecker, L. 2005: 40 Jahre Daueraufbringungsversuch DA/58 - ein Beitrag zur Boden- und Ertragsentwicklung landwirtschaftfich genutzter schwefel- und kohlehaltiger Kippenboden. Archives of Agronomy and Soil Science 51(2): 171-187

Siglienti, I.; Paulus, W.; Knauth, M.; Gold, R. 2006: 40-jahrige patintin mit progredienter sehstorung und entzundlichem liquor. Aktuelle Neurologie 33(2): 85-89

Gerdts, G.; Wichels, A.; Doepke, H.; Klings, K.-Walter; Gunkel, W.; Schuett, C. 2004: 40-year long-term study of microbial parameters near Helgoland (German Bight, North Sea): historical view and future perspectives. Helgoland Marine Research 58(4): 230-242

Bao-Chun-Mei; Qu-Fen; Guo-Tong-Sheng; Cui-En-Bo; Xu-Jun; Li-Xiao-Xiao; Mao-Yuan-Li 2004: 403 cases of mycoplasma infections and their drug susceptibility analysis. Zhongguo Kangshengsu Zazhi 29(11): 691-693

Wren, J.D. 2004: 404 not found: the stability and persistence of URLs published in MEDLINE. Bioinformatics 20(5): 668-672

Vitorovic, G.; Slavata, B.; Vitorovic, D. 2004: 40K I 137Cs U Gljivama Planine Maljen. Veterinarski Glasnik 58(3-4): 207-210

Czaplinski, K.; Mattaj, I.W. 2005: 40LoVe interacts with Vg1RBP/Vera and hnRNP I in binding the Vg1-localization element. Rna 12(2): 213-222

Anonymous 2004: 40th Workshop for Pediatric Research, Goettingen, Germany, February 19-20, 2004. European Journal of Pediatrics 163(2): R1-R12

Anonymous 2005: 41st Workshop for Pediatric Research, Gottingen, Germany, February 24-25, 2005. European Journal of Pediatrics 164(2): R2-R16

Guo, B. Zheng, P. Zou, Q. X.G. Lian; Jia Zheng, C. Zou, L.Y.; Zhou, W. Xie Pei Rong 2004: 42 residues of the amino terminus of alpha' chain fragment of C3b enhances cross-presentation of exogenous peptides antigens. Zhonghua Weishengwuxue He Mianyixue Zazhi 24(5): 341-344

Hammar, L. 2004: 4275 and counting: telling stories about STOs on Daru. Papua New Guinea Medical Journal 47(1-2): 88-113

Lee, P.A.; Witchel, S.F. 2005: 46,XX patients with congenital adrenal hyperplasia: Initial assignment as male, reassigned female. Journal of Pediatric Endocrinology and Metabolism: Jpem 18(2): 125-132

Seeherunvong, T.; Perera, E.M.; Bao, Y.; Benke, P.J.; Benigno, A.; Donahue, R.P.; Berkovitz, G.D. 2004: 46,XX sex reversal with partial duplication of chromosome arm 22q. American Journal of Medical Genetics. Part A 127a(2): 149-151

Tajima, T.; Sasaki, S.; Tanaka, Y.; Kusunoki, H.; Nagashima, T.; Nonomura, K.; Fujieda, K. 2003: 46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation. Hormone Research 60(6): 302-305

Heldmann, F.; Brandt, J.; Schoppe, H.; Braun, J. 2006: 46-jahriger patient mit granulomatoser prostatitis, arthralgien und blutiger rhinitis. DMW Deutsche Medizinische Wochenschrift 131(1-2): 22-25

Saavedra-Castillo, E.; Cortés-Gutiérrez, E.I.; Dávila-Rodríguez, M.I.; Reyes-Martínez, Mía.Eugenia.; Oliveros-Rodríguez, A. 2005: 47,XXY female with testicular feminization and positive SRY: a case report. Journal of Reproductive Medicine 50(2): 138-140

Duncan, G. 2003: 474. Cyrtanthus guthrieae: Amaryllidaceae. Curtis's Botanical Magazine 20(4): 190-195

Duncan, G. 2003: 475. Ammocharis nerinoides: Amaryllidaceae. Curtis's Botanical Magazine 20(4): 196-201

Duncan, G. 2003: 476. Lachenalia peersii: Hyacinthaceae. Curtis's Botanical Magazine 20(4): 202-207

Duncan, G. 2003: 477. Lachenalia salteri: Hyacinthaceae. Curtis's Botanical Magazine 20(4): 208-212

L.Croix, Isobyl 2003: 478. Cyrtorchis crassifolia: Orchidaceae. Curtis's Botanical Magazine 20(4): 213-218

Archer, R.H.; Victor, J.E. 2003: 479. Hoodia pilifera subsp. pillansii: Apocynaceae: Asclepiadoideae. Curtis's Botanical Magazine 20(4): 219-224

Hui, C-K.; Lai, L.S.W.; Lam, P.; Zhang, H-Y.; Fung, T-T.; Lai, S-T.; Wong, W-M.; Lo, C-M.; Fan, S-T.; Leung, N.; Lau, G.K.K. 2006: 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection. Alimentary Pharmacology and Therapeutics 23(8): 1171-1178

Lolak, S.; Dannemiller, E.; Andres, F. 2005: 48,XXYY syndrome, mood disorder, and aggression. American Journal of Psychiatry 162(7): 1384

Anonymous 2004: 48th Annual American Osteopathic Association (AOA) Research Conference, San Francisco, CA, USA, November 7-11, 2004. Journal of the American Osteopathic Association 104(8): 337-352

Chang, J-Tzong.; Chiu, P-Chin.; Chen, Y-Yao.; Chao, M-Chyn.; Hsieh, K-Sheng. 2005: 49, 4XY syndrome with severe vesico-ureteral reflux and hydronephrosis: report of one case. Acta Paediatrica Taiwanica 46(1): 35-38

Kim, H.Jin.; Kim, D.; Shin, J.Min.; Chung, H-Kyung.; Lee, G. 2005: 49,4XY syndrome with diabetes mellitus. Hormone Research 65(1): 14-17

Paganetti, H.; Jiang, H.; Trofimov, A. 2005: 4D Monte Carlo simulation of proton beam scanning: modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry. Physics in Medicine and Biology 50(5): 983-990

Slotman, B.J.; Lagerwaard, F.J.; Senan, S. 2006: 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncologica 45(7): 966-972

Park, J.; Larson, A.C.; Zhang, Q.; Simonetti, O.; Li, D. 2005: 4D radial coronary artery imaging within a single breath-hold: cine angiography with phase-sensitive fat suppression (CAPS). Magnetic Resonance in Medicine 54(4): 833-840

Da-Cunha, E.-Fontes-Ferreira; Albuquerque, M.-Girio; Antunes, O.-Augusto-Ceva; De-Alencastro, R.-Bicca 2005: 4D-QSAR models of HOE/BAY-793 analogues as HIV-1 protease inhihitors. QSAR and Combinatorial Science 24(2): 240-253

Teleman, A.A.; Chen, Y-Wen.; Cohen, S.M. 2005: 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes and Development 19(16): 1844-1848

Zhou, L.; Goldsmith, A.M.; Bentley, J.Kelley.; Jia, Y.; Rodriguez, M.L.; Abe, M.K.; Fingar, D.C.; Hershenson, M.B. 2005: 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. American Journal of Respiratory Cell and Molecular Biology 33(2): 195-202

Hoekstra, T.; Geleijnse, J.M.; Kluft, C.; Giltay, E.J.; Kok, F.J.; Schouten, E.G. 2003: 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34(12): 2822-2828

Böttiger, C.; Koch, W.; Lahn, C.; Mehilli, J.; von Beckerath, N.; Schömig, A.; Kastrati, A. 2003: 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. American Heart Journal 146(5): 855-861

Geishofer, G.; Binder, A.; Müller, M.; Zöhrer, B.; Resch, B.; Müller, W.; Faber, Jörg.; Finn, A.; Endler, G.; Mannhalter, C.; Zenz, W. 2005: 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. European Journal of Pediatrics 164(8): 486-490

Chen, C-Hung.; Eng, H-Liew.; Chang, C-Jen.; Tsai, T-Tung.; Lai, M-Liang.; Chen, H-Yen.; Liu, C-Ju.; Lin, T-Mei. 2003: 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. Journal of Laboratory and Clinical Medicine 142(2): 100-105

Egner, A.; Verrier, S.; Goroshkov, A.; Söling, H-Dieter.; Hell, S.W. 2004: 4Pi-microscopy of the Golgi apparatus in live mammalian cells. Journal of Structural Biology 147(1): 70-76

Levitt, G.A.; Platt, K.A.; De Byrne, R.; Sebire, N.; Owens, C.M. 2004: 4S neuroblastoma: the long-term outcome. Pediatric Blood and Cancer 43(2): 120-125

Stevenson, D.A.; Carey, J.C.; Cowley, B.C.; Bayrak-Toydemir, P.; Mao, R.; Brothman, A.R. 2004: 4p terminal deletion and 11p subtelomeric duplication detected by genomic microarray in a patient with Wolf-Hirschhorn syndrome and an atypical phenotype. Journal of Pediatrics 145(6): 840-842

Cingoz, S.; Bisgaard, A.M.; Bache, I.; Bryndorf, T.; Kirchoff, M.; Petersen, W.; Ropers, H-H.; Maas, N.; Van Buggenhout, G.; Tommerup, N.; Tümer, Z. 2006: 4q35 deletion and 10p15 duplication associated with immunodeficiency. American Journal of Medical Genetics. Part A 140(20): 2231-2235

Anonymous 2004: 4th International Workshop on Musculoskeletal and Neuronal Interactions, Chalkidiki, Greece, May 28-31, 2004. Journal of Musculoskeletal and Neuronal Interactions 4(2): 209-226

Anonymous 2004: 4th Muenster Workshop on Trace Elements and Electrolytes - AKTE 2/2002, Gelsenkirchen/Herne, Germany, November 23, 2002. Trace Elements and Electrolytes 21(2): 122-131

Qiu, G.; Fang, J.; He, Y. 2006: 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Clinical Biochemistry 39(3): 259-266

Kurose, K.; Koyano, S.; Ikeda, S.; Tohkin, M.; Hasegawa, R.; Sawada, J-Ichi. 2005: 5' diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site. Molecular and Cellular Biochemistry 273(1-2): 79-85

Koda, A.; Bogaki, T.; Minetoki, T.; Hirotsune, M. 2005: 5' Untranslated region of the Hsp12 gene contributes to efficient translation in Aspergillus oryzae. Applied Microbiology and Biotechnology 70(3): 333-336

Kelada, S.N.P.; Checkoway, H.; Kardia, S.L.R.; Carlson, C.S.; Costa-Mallen, P.; Eaton, D.L.; Firestone, J.; Powers, K.M.; Swanson, P.D.; Franklin, G.M.; Longstreth, W.T.; Weller, T-Smith.; Afsharinejad, Z.; Costa, L.G. 2006: 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study. Human Molecular Genetics 15(20): 3055-3062

Yim, D.-Jin; Han, J.-Hee; Ji, S.-Il; Hwang, S.-Gyu; Oh, D.; Kim, N.-Keun 2005: 5 ' and 3 ' untranslated region polymorphisms of thyinidylate synthase gene in Korean population. Korean Journal of Genetics 27(2): 161-168

Alexander, R.C.; Baum, D.A.; Testa, S.M. 2005: 5' transcript replacement in vitro catalyzed by a group I intron-derived ribozyme. Biochemistry 44(21): 7796-7804

Andriole, G. 2006: 5 alpha-reductase inhibitors and chemoprevention: The PCPT and beyond. European Urology Suppls 5(12): 746-751

Sheehan, P.M.; Rice, G.E.; Moses, E.K.; Brennecke, S.P. 2005: 5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term. Molecular Human Reproduction 11(7): 495-501

Cusini, M.; Salmaso, F.; Zerboni, R.; Carminati, G.; Vernaci, C.; Franchi, C.; Locatelli, A.; Alessi, E. 2004: 5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. International Journal of Std and Aids 15(1): 17-20

Wei, C-Lin.; Ng, P.; Chiu, K.Ping.; Wong, C.Hong.; Ang, C.Chin.; Lipovich, L.; Liu, E.T.; Ruan, Y. 2004: 5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation. Proceedings of the National Academy of Sciences of the United States of America 101(32): 11701-11706

Chen, B.; Bohnert, T.; Zhou, X.; Dedon, P.C. 2004: 5'-(2-phosphoryl-1,4-dioxobutane) as a product of 5'-oxidation of deoxyribose in DNA: elimination as trans-1,4-dioxo-2-butene and approaches to analysis. Chemical Research in Toxicology 17(11): 1406-1413

Tsuboi, T.; da Silva Xavier, G.; Leclerc, I.; Rutter, G.A. 2003: 5'-AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics. Journal of Biological Chemistry 278(52): 52042-52051

Rajappan, V.P.; Schneller, S.W. 2003: 5'-Amino-5'-deoxyaristeromycin and its antiviral properties. Bioorganic and Medicinal Chemistry 11(23): 5199-5201

Wu, Q.; Shi, H.; Suo, Z.; Nesland, J.M. 2003: 5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas. Ultrastructural Pathology 27(6): 417-422

Artykbayeva, G.M.; Turakulov, Y. 2004: 5'-Deiodinase expression in different thyroid tumors. Problemy Endokrinologii 50(3): 34-37

Takahashi, H.; Ieiri, I.; Wilkinson, G.R.; Mayo, G.; Kashima, T.; Kimura, S.; Otsubo, K.; Echizen, H. 2004: 5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients. Blood 103(8): 3055-3057

Hevia, H.; Varela-Rey, M.; Corrales, F.J.; Berasain, C.; Martínez-Chantar, Mía.L.; Latasa, M.Ujue.; Lu, S.C.; Mato, Jé.M.; García-Trevijano, E.R.; Avila, Mías.A. 2004: 5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 39(4): 1088-1098

Yin, X.-Qiang; Schneller, S., W. 2005: 5'-Noraristeromycin derivatives isomeric to aristeromycin and 2'-deoxyaristeromycin. Tetrahedron 61(7): 1839-1843

Yin, X.Q.; Schneller, S.W. 2004: 5'-Noraristeromycin possessing a C-1' cyclopentyl double bond: a new carbanucleoside structural prototype. Tetrahedron 60(15): 3451-3455

Stephens, T.J.; Canny, B.J.; Snow, R.J.; McConell, G.K. 2004: 5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle. Clinical and Experimental Pharmacology and Physiology 31(7): 419-423

Tuncbilek, M.; Schneller, S.W. 2003: 5'-nor carbocyclic ribavirin. Nucleosides Nucleotides and Nucleic Acids 22(11): 1995-2001

Bruno, A.Nejar.; Pochmann, D.; Ricachenevsky, F.Klein.; Bonan, C.Denise.; Barreto-Chaves, M.Luiza.M.; Freitas Sarkis, Jão.José. 2005: 5'-nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats. Platelets 16(1): 25-30

Tzao, C.; Tsai, H-Yuan.; Chen, J-Ta.; Chen, C-Yi.; Wang, Y-Ching. 2004: 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. European Journal of Cancer 40(14): 2175-2183

Kasai, Y.; Hashimoto, S-ichi.; Yamada, T.; Sese, J.; Sugano, S.; Matsushima, K.; Morishita, S. 2004: 5'SAGE: 5'-end Serial Analysis of Gene Expression database. Nucleic Acids Research 33(Database Issue): D550-D552

Xiao, Y.; Shan, K.; Li, Y.; Zhao, Y.; Qi, X.; Xie, Y.; Wu, C.; Ma, J.; Liu, H.; Xu, Y.; Guan, Z.; Ren, X. 2005: 5, 10-methylenetetrahydrofolate reductase polymorphism in three nationalities of Guizhou in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22(2): 219-221

Jarmuła, A.; Cieplak, P.; Montfort, W.R. 2005: 5,10-Methylene-5,6,7,8-tetrahydrofolate conformational transitions upon binding to thymidylate synthase: molecular mechanics and continuum solvent studies. Journal of Computer-Aided Molecular Design 19(2): 123-136

Ozkul, Y.; Evereklioglu, C.; Borlu, M.; Taheri, S.; Calis, M.; Dündar, M.; Ilhan, O. 2005: 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. British Journal of Ophthalmology 89(12): 1634-1637

Li, D.; Ahmed, M.; Li, Y.; Jiao, L.; Chou, T-Hsu.; Wolff, R.A.; Lenzi, R.; Evans, D.B.; Bondy, M.L.; Pisters, P.W.; Abbruzzese, J.L.; Hassan, M.M. 2005: 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(6): 1470-1476

Pereira, T.Veiga.; Rudnicki, M.; Pereira, A.Costa.; Pombo-de-Oliveira, M.S.; Franco, R.França. 2006: 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 15(10): 1956-1963

Stan, S.D.; Daeschel, M.A. 2005: 5,5-Dimethyl-2-pyrrolidone-N-oxyl formation in electron spin resonance studies of electrolyzed NaCl solution using 5,5-dimethyl-1-pyrroline-N-oxide as a spin trapping agent. Journal of Agricultural and Food Chemistry 53(12): 4906-4910

Farah, M.; Parhar, K.; Moussavi, M.; Eivemark, S.; Salh, B. 2003: 5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis. American Journal of Physiology. Gastrointestinal and Liver Physiology 285(5): G919-G928

Losapio, J.L.; Sprague, R.S.; Lonigro, A.J.; Stephenson, A.H. 2005: 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. Journal of Applied Physiology 99(4): 1391-1396

Olsen, C., A.; Parera, N.; Albericio, F.; Alvarez, M. 2005: 5,6-dihydropyrrolo(2,1-b)isoquinolines as scaffolds for synthesis of lamellarin analogues. Tetrahedron Letters 46(12): 2041-2044

Matthews, K.E.; Hermans, I.F.; Roberts, J.M.; Ching, L-Ming.; Ronchese, F. 2006: 5,6-Dimethylxanthenone-4-acetic acid treatment of a non-immunogenic tumour does not synergize with active or passive CD8+ T-cell immunotherapy. Immunology and Cell Biology 84(4): 383-389

Lieben, C.K.J.; Steinbusch, H.W.M.; Blokland, A. 2005: 5,7-DHT lesion of the dorsal raphe nuclei impairs object recognition but not affective behavior and corticosterone response to stressor in the rat. Behavioural Brain Research 168(2): 197-207

Limebeer, C.L.; Parker, L.A.; Fletcher, P.J. 2004: 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei interfere with lithium-induced conditioned gaping, but not conditioned taste avoidance, in rats. Behavioral Neuroscience 118(6): 1391-1399

Wen, X.; Walle, U.Kristina.; Walle, T. 2005: 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26(4): 803-809

Yu, S.; Deng, Z.; van Ofwegen, L.; Proksch, P.; Lin, W. 2006: 5,8-Epidioxysterols and related derivatives from a Chinese soft coral Sinularia flexibilis. Steroids 71(11-12): 955-959

Zhu, J.; Dhimitruka, I.; Pei, D. 2004: 5-(2-Aminoethyl)dithio-2-nitrobenzoate as a more base-stable alternative to Ellman's reagent. Organic Letters 6(21): 3809-3812

Bode, C.W.; Hänsel, W. 2005: 5-(3-Phenylpropoxy)psoralen and 5-(4-phenylbutoxy)psoralen: mechanistic studies on phototoxicity. Die Pharmazie 60(3): 225-228

Matulenko, M.A.; Lee, C-Hung.; Jiang, M.; Frey, R.R.; Cowart, M.D.; Bayburt, E.K.; Didomenico, S.; Gfesser, G.A.; Gomtsyan, A.; Zheng, G.Zhu.; McKie, J.A.; Stewart, A.O.; Yu, H.; Kohlhaas, K.L.; Alexander, K.M.; McGaraughty, S.; Wismer, C.T.; Mikusa, J.; Marsh, K.C.; Snyder, R.D.; Diehl, M.S.; Kowaluk, E.A.; Jarvis, M.F.; Bhagwat, S.S. 2005: 5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors. Bioorganic and Medicinal Chemistry 13(11): 3705-3720

Lee, E.; Choi, M-Kyung.; Youk, H-Jeong.; Kim, C.Hyeon.; Han, I-Oc.; Yoo, B-Chul.; Lee, M-Kyung.; Lim, S-Jeong. 2005: 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growth. Journal of Cancer Research and Clinical Oncology 132(4): 223-233

Kim, D.-Hyun; Kim, D.-Won; Choi, S.-Young; Park, C.-Ho; Baek, N.-In 2005: 5-(Hydroxymethyl)-2-furfuraldehyde, anticonvulsant furan from the Arils of Euphoria longana L. Agricultural Chemistry and Biotechnology 48(1): 32-34

Al Safarjalani, O.N.; Zhou, X-Jian.; Rais, R.H.; Shi, J.; Schinazi, R.F.; Naguib, F.N.M.; El Kouni, M.H. 2005: 5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens. Cancer ChemoTherapy and Pharmacology 55(6): 541-551

Fan, X.; Zhang, X.; Zhou, L.; Keith, K.A.; Kern, E.R.; Torrence, P.F. 2006: 5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity. Journal of Medicinal Chemistry 49(11): 3377-3382

Giannini, E.G.; Kane, S.V.; Testa, R.; Savarino, V. 2005: 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 37(10): 723-731

Mai, A.; Artico, M.; Ragno, R.; Sbardella, G.; Massa, S.; Musiu, C.; Mura, M.; Marturana, F.; Cadeddu, A.; Maga, G.; La Colla, P. 2005: 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family. Bioorganic and Medicinal Chemistry 13(6): 2065-2077

Wrobel, J.; Jetter, J.; Kao, W.; Rogers, J.; Di, L.; Chi, J.; Peréz, M.Claudia.; Chen, G-Chung.; Shen, E.S. 2006: 5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists. Bioorganic and Medicinal Chemistry 14(16): 5729-5741

Skorobogatyi, M., V.; Pchelintseva, A., A.; Petrunina, A., L.; Stepanova, T., A.; Andronova, V., L.; Galegov, G., A.; Malakhov, A., D.; Korshun, V., A. 2006: 5-Alkynyl-2 '-deoxyuridines, containing bulky aryl groups: evaluation of structure-anti-HSV-1 activity relationship. Tetrahedron 62(6): 1279-1287

Wang, C-Zheng.; Wang, Y.; Di, A.; Magnuson, M.A.; Ye, H.; Roe, M.W.; Nelson, D.J.; Bell, G.I.; Philipson, L.H. 2005: 5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochemical and Biophysical Research Communications 330(4): 1073-1079

Nath, N.; Giri, S.; Prasad, R.; Salem, M.Labib.; Singh, A.K.; Singh, I. 2005: 5-Aminoimidazole-4-carboxamide ribonucleoside: A novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. Journal of Immunology 175(1): 566-574

Walker, J.; Jijon, H., B.; Diaz, H.; Salehi, P.; Churchill, T.; Madsen, K., L. 2005: 5-Aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AWPK. Biochemical Journal 385(Part 2): 485-491

Jhun, B.Sook.; Jin, Q.; Oh, Y.Taek.; Kim, S.Soo.; Kong, Y.; Cho, Y.Ho.; Ha, J.; Baik, H.Hwan.; Kang, I. 2004: 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochemical and Biophysical Research Communications 318(2): 372-380

Giri, S.; Nath, N.; Smith, B.; Viollet, B.; Singh, A.K.; Singh, I. 2004: 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(2): 479-487

Pencek, R.Richard.; Shearer, J.; Camacho, R.C.; James, F.D.; Lacy, D.Brooks.; Fueger, P.T.; Donahue, E.Patrick.; Snead, W.; Wasserman, D.H. 2005: 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo. Diabetes 54(2): 355-360

Rattan, R.; Giri, S.; Singh, A.K.; Singh, I. 2005: 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. Journal of Biological Chemistry 280(47): 39582-39593

Camacho, R.C.; Lacy, D.Brooks.; James, F.D.; Donahue, E.Patrick.; Wasserman, D.H. 2005: 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin. American Journal of Physiology. Endocrinology and Metabolism 289(6): E1039-E1043

Cuzzocrea, S.; Mazzon, E.; Di Paola, R.; Genovese, T.; Patel, N.S.A.; Muià, C.; Threadgill, M.D.; De Sarro, A.; Thiemermann, C. 2004: 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn-Schmiedeberg's Archives of Pharmacology 370(6): 464-473

Chatterjee, P.K.; Chatterjee, B.E.; Pedersen, H.; Sivarajah, A.; McDonald, M.C.; Mota-Filipe, H.; Brown, P.A.J.; Stewart, K.N.; Cuzzocrea, S.; Threadgill, M.D.; Thiemermann, C. 2004: 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion. Kidney International 65(2): 499-509

Sawada, T.-Cristina-Higashi; Da-Silva, V.-Vitoriano; Barros, S.; Ropke, C.-Dislich; Barros, S.-Berlanga-De-Moraes 2004: 5-Aminolevulinic acid and the hepatic oxidative stress in the early phase of experimental hexachlorobenzene intoxication. Revista Brasileira de Ciencias Farmaceuticas 40(2): 203-208

Vena, F.C.B.; Turchiello, R.F.; Laville, I.; Pigaglio, S.; Blais, J.; Tedesco, A.C. 2004: 5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line. Lasers in Medical Science 19(2): 119-126

Hage, M.; Siersema, P.D.; van Dekken, H.; Steyerberg, E.W.; Haringsma, J.; van de Vrie, W.; Grool, T.E.; van Veen, R.L.P.; Sterenborg, H.J.C.M.; Kuipers, E.J. 2004: 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 53(6): 785-790

Zhang, S-Juan.; Zhang, Z-Xi. 2004: 5-Aminolevulinic acid-based photodynamic therapy in leukemia cell HL60. Photochemistry and Photobiology 79(6): 545-550

Gamarra, F.; Lingk, P.; Marmarova, A.; Edelmann, M.; Hautmann, H.; Stepp, H.; Baumgartner, R.; Huber, R.M. 2004: 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: Dependency on the patterns of tumour invasion. Journal of Photochemistry and Photobiology. B Biology 73(1-2): 35-42

Alexeeva, I.V.; Palchikovs'ka, L.G.; Usenko, L.S.; Kostina, V.G. 2005: 5-Aminosubstituted triazine nucleosides and their furanidylic analogues: synthesis and primary screening on tumor cell models. Biopolimery i Kletka 21(2): 174-179

Hao, C-lai.; Tang, K-jing.; Chen, S.; Xing, H-yan.; Wang, M.; Wang, J-xiang. 2005: 5-Aza-2'-deoxycytidine enhances differentiation and apoptosis induced by phenylbutyrate in Kasumi-1 cells. Zhonghua Zhong Liu Za Zhi 27(3): 148-151

Kelly, T.L.J.; Li, E.; Trasler, J.M. 2003: 5-Aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome. Journal of Andrology 24(6): 822-830

Schmelz, K.; Wagner, M.; Dörken, B.; Tamm, I. 2004: 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia. International Journal of Cancer 114(5): 683-695

Cvetkovic, I.; Popadic, D.; Vuckovic, O.; Harhaji, L.; Miljkovic, D.; Trajkovic, V. 2004: 5-Aza-2'-deoxycytidine stimulates inducible nitric oxide synthase induction in C6 astrocytoma cells. Brain Research 998(1): 83-90

Ghoshal, K.; Datta, J.; Majumder, S.; Bai, S.; Kutay, H.; Motiwala, T.; Jacob, S.T. 2005: 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Molecular and Cellular Biology 25(11): 4727-4741

Kuykendall, J.R. 2005: 5-azacytidine and decitabine monotherapies of myelodysplastic disorders. Annals of PharmacoTherapy 39(10): 1700-1709

Wada, H.; Kagoshima, M.; Ito, K.; Barnes, P.J.; Adcock, I.M. 2005: 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene. Biochemical and Biophysical Research Communications 331(1): 93-99

Pullagurla, M.; Dukat, M.; Roth, B., L.; Setola, V.; Glennon, R., A. 2005: 5-Azatryptamine analogs as h5-HT6 serotonin receptor ligands. Medicinal Chemistry Research 14(1): 1-18

Carmi, C.; Cavazzoni, A.; Zuliani, V.; Lodola, A.; Bordi, F.; Plazzi, P.Vincenzo.; Alfieri, R.R.; Petronini, P.Giorgio.; Mor, M. 2006: 5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. Bioorganic and Medicinal Chemistry Letters 16(15): 4021-4025

Sulsky, R.; Robl, J.A.; Biller, S.A.; Harrity, T.W.; Wetterau, J.; Connolly, F.; Jolibois, K.; Kunselman, L. 2004: 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP. Bioorganic and Medicinal Chemistry Letters 14(20): 5067-5070

Wright, S.W.; Rath, V.L.; Genereux, P.E.; Hageman, D.L.; Levy, C.B.; McClure, L.D.; McCoid, S.C.; McPherson, R.Kirk.; Schelhorn, T.M.; Wilder, D.E.; Zavadoski, W.J.; Gibbs, E.Michael.; Treadway, J.L. 2004: 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization. Bioorganic and Medicinal Chemistry Letters 15(2): 459-465

Rayat, S.; Glaser, R. 2003: 5-cyanoimino-4-oxomethylene-4,5-dihydroimidazole and nitrosative guanine deamination. A theoretical study of geometries, electronic structures, and N-protonation. Journal of Organic Chemistry 68(26): 9882-9892

Thorsteinsson, M.V.; Richter, J.; Lee, A.L.; DePhillips, P. 2005: 5-Dodecanoylaminofluorescein as a probe for the determination of critical micelle concentration of detergents using fluorescence anisotropy. Analytical Biochemistry 340(2): 220-225

Rao, M.Srinivasa.; Esho, N.; Sergeant, C.; Dembinski, R. 2003: 5-Endo-dig electrophilic cyclization of alpha-alkynyl carbonyl compounds: synthesis of novel bicyclic 5-iodo- and 5-bromofuranopyrimidine nucleosides. Journal of Organic Chemistry 68(17): 6788-6790

An, M.; Maitra, U.; Neidlein, U.; Bartlett, P.A. 2003: 5-enolpyruvylshikimate 3-phosphate synthase: chemical synthesis of the tetrahedral intermediate and assignment of the stereochemical course of the enzymatic reaction. Journal of the American Chemical Society 125(42): 12759-12767

Priestman, M.A.; Funke, T.; Singh, I.M.; Crupper, S.S.; Schönbrunn, E. 2005: 5-Enolpyruvylshikimate-3-phosphate synthase from Staphylococcus aureus is insensitive to glyphosate. Febs Letters 579(3): 728-732

Fukuda, Kousei; Koizumi, Koichi; Et-Al 2000: 5-FU induced colitis, report of a case. Stomach and Intestine 35(9): 1185-1190

Mahteme, H.; Sundin, A.; Larsson, B.; Khamis, H.; Arow, K.; Graf, W. 2005: 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat. Anticancer Research 25(2a): 917-922

Hallinan, E.Ann.; Hagen, T.J.; Bergmanis, A.; Moore, W.M.; Jerome, G.M.; Spangler, D.P.; Stevens, A.M.; Shieh, H.S.; Manning, P.T.; Pitzele, B.S. 2004: 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors. Journal of Medicinal Chemistry 47(4): 900-906

Curbo, S.; Johansson, M.; Karlsson, A. 2004: 5-Fluoro-2'-deoxyuridine has effects on mitochondria in CEM T-lymphoblast cells. Nucleosides Nucleotides and Nucleic Acids 23(8-9): 1495-1498

Allegrini, G.; Falcone, A.; Di Marsico, R.; Lencioni, M.; Masi, G.; Galli, C.; Cupini, S.; Pfanner, E.; Marcucci, L.; Conte, P.Franco. 2004: 5-fluorouracil administered as a 48-hour semiintermittent infusion in combination with leucovorin, cisplatin and epirubicin: phase II study in advanced gastric cancer patients. American Journal of Clinical Oncology 27(1): 101-105

Pascu, M.Lucian.; Brezeanu, M.; Voicu, L.; Staicu, A.; Carstocea, B.; Pascu, R.Angela. 2005: 5-fluorouracil as a phosensitiser. In Vivo 19(1): 215-220

Yadav, B.S.; Sharma, S.C. 2005: 5-Fluorouracil associated encephalopathy: Case report. Indian Journal of Pharmacology 37(2): 130-131

Formica, V.; Leary, A.; Cunningham, D.; Chua, Y.J. 2005: 5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma. Cancer ChemoTherapy and Pharmacology 58(2): 276-278

Innocenti, F.; Danesi, R.; Bocci, G.; Natale, G.; Del Tacca, M. 2005: 5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice. Toxicology and Applied Pharmacology 203(2): 106-113

Saif, M.Wasif.; von Borstel, R. 2005: 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice. Cancer ChemoTherapy and Pharmacology 58(1): 136-142

Gordon, S.R.; Climie, M.; Hitt, A.L. 2005: 5-Fluorouracil interferes with actin organization, stress fiber formation and cell migration in corneal endothelial cells during wound repair along the natural basement membrane. Cell Motility and the Cytoskeleton 62(4): 244-258

Kinoshita, K.; Yonemura, Y.; Sawa, T.; Miyata, T.; Sakuma, H.; Matsuki, N.; Tanaka, S.; Fushida, S.; Fujimura, T.; Mok, Y.Jai.; Kim, B.Sik.; Lee, J.In.; Choi, D.Wook.; Song, Y.Jin.; Yang, D.Hyun.; Kwon, S.Joon.; Tanaka, M.; Miyazaki, I. 2003: 5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancer. Hepato-Gastroenterology 50(53): 1716-1719

Blanco, M.D.; Sastre, R.L.; Teijón, C.; Olmo, R.; Teijón, J.M. 2006: 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release. Journal of Microencapsulation 22(6): 671-682

Kuramochi, H.; Hayashi, K.; Uchida, K.; Miyakura, S.; Shimizu, D.; Vallbohmer, D.; Park, S.; Danenberg, K.D.; Takasaki, K.; Danenberg, P.V. 2006: 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis. International Journal of Cancer 119(3): 522-526

Steiner, M.; Seule, M.; Steiner, B.; Bauer, I.; Freund, M.; Köhne, C.H.; Schuff-Werner, P. 2005: 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case. Journal of Clinical Pathology 58(5): 553-555

Lehr, T.; Schipp, R. 2005: 5-HT 2 and 3 agonists influence the contraction activity of the auricles from the central heart complex of Sepia officinalis L. (Cephalopoda). Zoological Studies 44(4): 468-474

Cloëz-Tayarani, I.; Kayyali, U.S.; Fanburg, B.L.; Cavaillon, J-Marc. 2004: 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors. Life Sciences 76(4): 429-443

Sood, S.; Liu, X.; Liu, H.; Nolan, P.; Horner, R.L. 2003: 5-HT at hypoglossal motor nucleus and respiratory control of genioglossus muscle in anesthetized rats. Respiratory Physiology and Neurobiology 138(2-3): 205-221

Marcoli, M.; Cervetto, C.; Castagnetta, M.; Sbaffi, P.; Maura, G. 2004: 5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices. Neurochemistry International 45(5): 687-691

Peng, Y-Jie.; Yuan, G.; Jacono, F.J.; Kumar, G.K.; Prabhakar, N.R. 2006: 5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase. Journal of Physiology 576(Pt 1): 289-295

Géranton, S.M.; Heal, D.J.; Stanford, S.Clare. 2004: 5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354. Neuropharmacology 46(4): 511-518

Watts, S.W. 2005: 5-HT in systemic hypertension: foe, friend or fantasy?. Clinical Science 108(5): 399-412

Simon, A.R.; Severgnini, M.; Takahashi, S.; Rozo, L.; Andrahbi, B.; Agyeman, A.; Cochran, B.H.; Day, R.M.; Fanburg, B.L. 2005: 5-HT induction of c-fos gene expression requires reactive oxygen species and Rac1 and Ras GTPases. Cell Biochemistry and Biophysics 42(3): 263-276

Hill, R.H.; Svensson, E.; Dewael, Y.; Grillner, S. 2003: 5-HT inhibits N-type but not L-type Ca(2+) channels via 5-HT1A receptors in lamprey spinal neurons. European Journal of Neuroscience 18(11): 2919-2924

Martinez-Larranaga, M., R.; Anadon, A.; Martinez, M., A.; Martinez, M.; Castellano, V., J.; Diaz, M., J. 2003: 5-HT loss in rat brain by type II pyrethroid insecticides. Toxicology and Industrial Health 19(7-10): 147-155

Biró, Z.án.; Hill, R.H.; Grillner, S. 2006: 5-HT Modulation of identified segmental premotor interneurons in the lamprey spinal cord. Journal of Neurophysiology 96(2): 931-935

Cai-Sheng-Rong; Huang-Zhen-Xin 2006: 5-HT receptor subtype-mediated depolarization in guinea pig celiac ganglion neurons. Zhongguo Yaolixue Tongbao 22(7): 865-869

Salchner, P.; Singewald, N. 2006: 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats. Psychopharmacology 185(3): 282-288

Lo, W.Caroline.; Jackson, E.; Merriman, A.; Harris, J.; Clarke, R.W. 2004: 5-HT receptors involved in opioid-activated descending inhibition of spinal withdrawal reflexes in the decerebrated rabbit. Pain 109(1-2): 162-171

Carroll, M.; Warren, O.; Fan, X.; Sossin, W.S. 2004: 5-HT stimulates eEF2 dephosphorylation in a rapamycin-sensitive manner in Aplysia neurites. Journal of Neurochemistry 90(6): 1464-1476

Mantovani, M.; Bubl, B.; Feuerstein, T.J. 2005: 5-HT uptake blockade prevents the increasing effect of K(ATP) channel blockers on electrically evoked [3H]-5-HT release in rat and mouse neocortical slices. Neurochemistry International 48(3): 218-225

Comet, M-Anne.; Sévoz-Couche, C.; Hanoun, Nïma.; Hamon, M.; Laguzzi, R. 2004: 5-HT-mediated inhibition of cardiovagal baroreceptor reflex response during defense reaction in the rat. American Journal of Physiology. Heart and Circulatory Physiology 287(4): H1641-H1649

de Boer, S.F.; Koolhaas, J.M. 2005: 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. European Journal of Pharmacology 526(1-3): 125-139

Pobbe, R.L.H.; Zangrossi, Hélio. 2005: 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology 183(3): 314-321

Sempere, Tésfora.; Urbina, M.; Lima, L. 2004: 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes. Neuroimmunomodulation 11(5): 307-315

Lorenzi, C.; Serretti, A.; Mandelli, L.; Tubazio, V.; Ploia, C.; Smeraldi, E. 2005: 5-HT 1A polymorphism and self-transcendence in mood disorders. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 137b(1): 33-35

Rioja, J.é; Santín, L.J.; Doña, A.; de Pablos, L.; Minano, F.J.; Gonzalez-Baron, S.; Aguirre, J.A. 2006: 5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat. Neuroscience Letters 397(3): 190-195

Li, X.; Inoue, T.; Abekawa, T.; Weng, S.; Nakagawa, S.; Izumi, T.; Koyama, T. 2006: 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. European Journal of Pharmacology 532(1-2): 74-80

Bezard, E.; Gerlach, I.; Moratalla, R.; Gross, C.E.; Jork, R. 2006: 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiology of Disease 23(1): 77-86

López-Meraz, Mía-Leonor.; González-Trujano, Mía-Eva.; Neri-Bazán, L.; Hong, E.; Rocha, L.Lilia. 2005: 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 49(3): 367-375

Luna-Munguía, H.; Manuel-Apolinar, L.; Rocha, L.; Meneses, A. 2005: 5-HT1A receptor expression during memory formation. Psychopharmacology 181(2): 309-318

Palchaudhuri, M.; Flügge, G. 2005: 5-HT1A receptor expression in pyramidal neurons of cortical and limbic brain regions. Cell and Tissue Research 321(2): 159-172

Kitamura, Y.; Araki, H.; Shibata, K.; Gomita, Y.; Tanizaki, Y. 2003: 5-HT(1A) receptor full agonist, 8-OH-DPAT, exerts antidepressant-like effects in the forced swim test in ACTH-treated rats. European Journal of Pharmacology 481(1): 75-77

De Vry, J.; Schreiber, R.; Melon, C.; Dalmus, M.; Jentzsch, K.R. 2004: 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 14(6): 487-495

Antri, M.; Mouffle, C.; Orsal, D.; Barthe, J-Y. 2003: 5-HT1A receptors are involved in short- and long-term processes responsible for 5-HT-induced locomotor function recovery in chronic spinal rat. European Journal of Neuroscience 18(7): 1963-1972

Cowen, D.S.; Johnson-Farley, N.N.; Travkina, T. 2005: 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons. Journal of Neurochemistry 93(4): 910-917

Wei, H.; Pertovaara, A. 2006: 5-HT(1A) receptors in endogenous regulation of neuropathic hypersensitivity in the rat. European Journal of Pharmacology 535(1-3): 157-165

Grunnet, M.; Jespersen, T.; Perrier, J-François. 2004: 5-HT1A receptors modulate small-conductance Ca2+-activated K+ channels. Journal of Neuroscience Research 78(6): 845-854

Torres-Escalante, Jé.L.; Barral, J.A.; Ibarra-Villa, Mía.D.; Pérez-Burgos, A.; Góngora-Alfaro, Jé.L.; Pineda, J.C. 2004: 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol. Journal of Neuroscience Research 78(2): 268-278

Mizutani, H.; Hori, T.; Takahashi, T. 2006: 5-HT1B receptor-mediated presynaptic inhibition at the calyx of Held of immature rats. European Journal of Neuroscience 24(7): 1946-1954

Bramley, J.R.; Sollars, P.J.; Pickard, G.E.; Dudek, F.Edward. 2005: 5-HT1B receptor-mediated presynaptic inhibition of GABA release in the suprachiasmatic nucleus. Journal of Neurophysiology 93(6): 3157-3164

Chenu, F.; Dailly, E.; Bourin, M. 2005: 5-HT1B receptor: A target for antidepressant drugs?. Drug Development Research 65(3): 141-146

Olivier, B.; van Oorschot, R. 2005: 5-HT1B receptors and aggression: a review. European Journal of Pharmacology 526(1-3): 207-217

Valdivia, L.F.; Centurión, D.; Arulmani, U.; Saxena, P.R.; Villalón, C.M. 2004: 5-HT1B receptors, alpha2A/2C- and, to a lesser extent, alpha1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs. Naunyn-Schmiedeberg's Archives of Pharmacology 370(1): 46-53

De Almeida, R.M.M.; Rosa, M.M.; Santos, D.M.; Saft, D.M.; Benini, Q.; Miczek, K.A. 2006: 5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice. Psychopharmacology 185(4): 441-450

Suwattanasophon, C.; Phansuwan-Pujito, P.; Srikiatkhachorn, A. 2003: 5-HT(1B/1D) serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway. Cephalalgia: An International Journal of Headache 23(8): 825-832

Ramadan, N.M.; Skljarevski, V.; Phebus, L.A.; Johnson, K.W. 2003: 5-HT1F receptor agonists in acute migraine treatment: A hypothesis. Cephalalgia: An International Journal of Headache 23(8): 776-785

Sanberg, C.Davis.; Jones, F.L.; Do, V.H.; Dieguez, D.; Derrick, B.E. 2006: 5-HT1a receptor antagonists block perforant path-dentate LTP induced in novel, but not familiar, environments. Learning and Memory 13(1): 52-62

Harvey, P.J.; Li, X.; Li, Y.; Bennett, D.J. 2006: 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. Journal of Neurophysiology 96(3): 1158-1170

Rajesh, K.Gopalrao.; Suzuki, R.; Maeda, H.; Murio, Y.; Sasaguri, S. 2006: 5-HT2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury. Life Sciences 79(18): 1749-1755

An, J.; Chen, C-Hua.; Guan, B-cai.; Tang, M.; Yu, C-gao.; Li, Z-wang. 2005: 5-HT2 receptor mediated the potentiation of GABA-activated current in the membrane of the dorsal root ganglion neurons of rat. Yao Xue Xue Bao 40(1): 1-7

Bourin, M.; Dhonnchadha, B.-Aine-Nic 2005: 5-HT2 receptors and anxiety. Drug Development Research 65(3): 133-140

Olijslagers, J.E.; Werkman, T.R.; McCreary, A.C.; Siarey, R.; Kruse, C.G.; Wadman, W.J. 2004: 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat. Neuropharmacology 46(4): 504-510

Winstanley, C.A.; Theobald, D.E.H.; Dalley, J.W.; Glennon, J.C.; Robbins, T.W. 2004: 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176(3-4): 376-385

Auclair, Aès.; Drouin, C.; Cotecchia, S.; Glowinski, J.; Tassin, J-Pol. 2004: 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. European Journal of Neuroscience 20(11): 3073-3084

Matsumoto, I.; Inoue, Y.; Iwazaki, T.; Pavey, G.; Dean, B. 2005: 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study. Neuroscience Letters 379(3): 164-168

Nomura, S.; Shouzu, A.; Omoto, S.; Nishikawa, M.; Iwasaka, T. 2005: 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 16(6): 423-428

Göőz, M.; Göőz, P.; Luttrell, L.M.; Raymond, J.R. 2006: 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. Journal of Biological Chemistry 281(30): 21004-21012

Qu, Y.; Villacreses, N.; Murphy, D.L.; Rapoport, S.I. 2005: 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology 180(1): 12-20

Huang, X-Feng.; Huang, X.; Han, M.; Chen, F.; Storlien, L.; Lawrence, A.J. 2004: 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Research 1018(2): 227-235

Zhang, G-rong.; Gao, D-lian.; Cao, L-guang.; Yin, M. 2004: 5-HT2C receptor subtype modulate production of secretory beta-amyloid protein precursor in incubated rat hippocampal slices. Yao Xue Xue Bao 39(5): 321-324

Jakus, R.; Graf, M.; Juhasz, G.; Gerber, K.; Levay, G.; Halasz, P.; Bagdy, G. 2004: 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Experimental Neurology 184(2): 964-972

Hackler, E.A.; Airey, D.C.; Shannon, C.C.; Sodhi, M.S.; Sanders-Bush, E. 2006: 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice. Neuroscience Research 55(1): 96-104

Mhatre, M.; Pruthi, R.; Hensley, K.; Holloway, F. 2004: 5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake. European Journal of Pharmacology 491(2-3): 149-156

Pham, L.; Langford, J.; Williams, K. 2003: 5-HT3 antagonists in the treatment of postoperative nausea and vomiting. Journal of Pharmacy Practice and Research 33(4): 275-278

Barnes, N.M. 2005: 5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!. Gut 54(8): 1056-1057

Constenla, M. 2004: 5-HT3 receptor antagonists for prevention of late acute-onset emesis. Annals of PharmacoTherapy 38(10): 1683-1691

Mckenzie-Quirk, S.D.; Girasa, K.A.; Allan, A.M.; Miczek, K.A. 2005: 5-HT(3) receptors, alcohol and aggressive behavior in mice. Behavioural Pharmacology 16(3): 163-169

Mori, T.; Kawano, K-Ichi.; Shishikura, T. 2004: 5-HT3-receptor antagonist inhibits visceral pain differently in chemical and mechanical stimuli in rats. Journal of Pharmacological Sciences 94(1): 73-76

Aapro, M. 2005: 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 69(2): 97-109

Huang, J.; Spier, A.D.; Pickel, V.M. 2004: 5-HT3A receptor subunits in the rat medial nucleus of the solitary tract: subcellular distribution and relation to the serotonin transporter. Brain Research 1028(2): 156-169

Mlinar, B.; Mascalchi, S.; Mannaioni, G.; Morini, R.; Corradetti, R. 2006: 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons. European Journal of Neuroscience 24(3): 719-731

Doly, Séphane.; Fischer, J.; Brisorgueil, M-Jeanne.; Vergé, D.; Conrath, M. 2004: 5-HT5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature. Journal of Comparative Neurology 476(4): 316-329

Lacroix, L.P.; Dawson, L.A.; Hagan, J.J.; Heidbreder, C.A. 2003: 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51(2): 158-164

Hatcher, P.D.; Brown, V.J.; Tait, D.S.; Bate, S.; Overend, P.; Hagan, J.J.; Jones, D.N.C. 2005: 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology 181(2): 253-259

Hedlund, P.B.; Huitron-Resendiz, S.; Henriksen, S.J.; Sutcliffe, J.Gregor. 2005: 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biological Psychiatry 58(10): 831-837

Kvachnina, E.; Liu, G.; Dityatev, A.; Renner, U.; Dumuis, A.; Richter, D.W.; Dityateva, G.; Schachner, M.; Voyno-Yasenetskaya, T.A.; Ponimaskin, E.G. 2005: 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(34): 7821-7830

Siddiqui, A.; Abu-Amara, M.; Aldairy, C.; Hagan, J.J.; Wilson, C. 2004: 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta. European Journal of Pharmacology 491(1): 77-84

Tokarski, K.; Zahorodna, A.; Bobula, B.; Hess, G. 2003: 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Research 993(1-2): 230-234

Tonini, M.; Vicini, R.; Cervio, E.; De Ponti, F.; De Giorgio, R.; Barbara, G.; Stanghellini, V.; Dellabianca, A.; Sternini, C. 2005: 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129(5): 1557-1566

Centurión, D.; Glusa, E.; Sánchez-López, A.; Valdivia, L.F.; Saxena, P.R.; Villalón, C.M. 2004: 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. European Journal of Pharmacology 502(3): 239-242

Arias, Bárbara.; Catalán, R.; Gastó, Cóbal.; Gutiérrez, B.; Fañanás, L. 2003: 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. Journal of Clinical Psychopharmacology 23(6): 563-567

Valinluck, V.; Liu, P.; Kang, J.I.; Burdzy, A.; Sowers, L.C. 2005: 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Research 33(9): 3057-3064

Sakya, S.M.; DeMello, K.M.Lundy.; Minich, M.L.; Rast, B.; Shavnya, A.; Rafka, R.J.; Koss, D.A.; Cheng, H.; Li, J.; Jaynes, B.H.; Ziegler, C.B.; Mann, D.W.; Petras, C.F.; Seibel, S.B.; Silvia, A.M.; George, D.M.; Lund, L.A.; St Denis, S.; Hickman, A.; Haven, M.L.; Lynch, M.P. 2005: 5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog. Bioorganic and Medicinal Chemistry Letters 16(2): 288-292

Maoka, T.; Fujiwara, Y.; Hashimoto, K.; Akimoto, N. 2006: 5-Hydroxy-seco-carotenoids from Pittosporum tobira. Phytochemistry 67(19): 2120-2125

Hanley, P., J.; Droese, S.; Brandt, U.; Lareau, R., A.; Banerjee, A., L.; Srivastava, D.K.; Banaszak, L., J.; Barycki, J., J.; Van-Veldhoven, P., P.; Daut, J. 2005: 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. Journal of Physiology (Oxford) 562(2): 307-318

Blessing, W.W. 2004: 5-Hydroxytryptamine 1A receptor activation reduces cutaneous vasoconstriction and fever associated with the acute inflammatory response in rabbits. Neuroscience 123(1): 1-4, 5 January

Madjid, N.; Tottie, E.Elvander.; Lüttgen, M.; Meister, Börn.; Sandin, J.; Kuzmin, A.; Stiedl, O.; Ogren, S.Ove. 2005: 5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms. Journal of Pharmacology and Experimental Therapeutics 316(2): 581-591

Osei-Owusu, P.; James, A.; Crane, J.; Scrogin, K.E. 2005: 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. Journal of Pharmacology and Experimental Therapeutics 313(3): 1324-1330

Ootsuka, Y.; Blessing, W.W. 2003: 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits. Journal of Physiology 552(Pt 1): 303-314

Matsusaka, S.; Wakabayashi, I. 2005: 5-Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells. Febs Letters 579(30): 6721-6725

Matsusaka, S.; Wakabayashi, I. 2005: 5-Hydroxytryptamine augments migration of human aortic smooth muscle cells through activation of RhoA and ERK. Biochemical and Biophysical Research Communications 337(3): 916-921

Stanford, I.M.; Kantaria, M.A.; Chahal, H.S.; Loucif, K.C.; Wilson, C.L. 2005: 5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors. Neuropharmacology 49(8): 1228-1234

Ikeda, K.; Tojo, K.; Otsubo, C.; Udagawa, T.; Kumazawa, K.; Ishikawa, M.; Tokudome, G.; Hosoya, T.; Tajima, N.; Claycomb, W.C.; Nakao, K.; Kawamura, M. 2005: 5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochemical and Biophysical Research Communications 328(2): 522-525

Aapro, M.; Blower, P. 2005: 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?. Cancer 104(1): 1-18

Holmes, G.M. 2005: 5-Hydroxytryptamine2C receptors on pudendal motoneurons innervating the external anal sphincter. Brain Research 1057(1-2): 65-71

Verheggen, R.; Werner, I.; Lücker, A.; Brüss, M.; Göthert, M.; Kaumann, A.J. 2006: 5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals. Pharmacogenetics and Genomics 16(8): 601-607

Song, D.; Wang, H-liang.; Wang, S.; Zhang, X-hua. 2005: 5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent. Acta Pharmacologica Sinica 26(5): 563-567

Calama, E.; García, M.; Jarque, M.J.; Morán, A.; Martín, M.L.; San Román, L. 2003: 5-Hydroxytryptamine-induced vasodilator responses in the hindquarters of the anaesthetized rat, involve beta2-adrenoceptors. Journal of Pharmacy and Pharmacology 55(10): 1371-1378

Wang, W.; Wu, S-Xi.; Wang, Y-Yun.; Liu, X-Yu.; Li, Y-Qing. 2003: 5-Hydroxytryptamine1A receptor is involved in the bee venom induced inflammatory pain. Pain 106(1-2): 135-142

Levita, L.; Hammack, S.E.; Mania, I.; Li, X-Y.; Davis, M.; Rainnie, D.G. 2004: 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies. Neuroscience 128(3): 583-596

Turner, E.H.; Blackwell, A.D. 2005: 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Medical Hypotheses 65(1): 138-144

Beck, O.; Helander, A. 2003: 5-Hydroxytryptophol as a marker for recent alcohol intake. Addiction 98(Suppl 2): 63-72

Shimizu, I.; Iida, T.; Horiuchi, N.; Caterina, M.J. 2005: 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro. Journal of Pharmacology and Experimental Therapeutics 314(3): 1378-1385

Green, J.Angelo.; Stockton, R.A.; Johnson, C.; Jacobson, B.S. 2004: 5-lipoxygenase and cyclooxygenase regulate wound closure in NIH/3T3 fibroblast monolayers. American Journal of Physiology. Cell Physiology 287(2): C373-C383

Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M. 2004: 5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking. FASEB Journal 18(14): 1740-1742

Hardy, G.; Vergnaud, S.; Lunardi, J.; Peoc'h, M.; Bessard, G.; Stanke-Labesque, F. 2005: 5-Lipoxygenase expression and activity in aorta from streptozotocin-induced diabetic rats. Prostaglandins and Other Lipid Mediators 75(1-4): 91-103

Lewis, T.A.; Bayless, L.; DiPesa, A.J.; Eckman, J.B.; Gillard, M.; Libertine, L.; Scannell, R.T.; Wypij, D.M.; Young, M.A. 2005: 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds. Bioorganic and Medicinal Chemistry Letters 15(4): 1083-1085

Matsuyama, M.; Yoshimura, R.; Mitsuhashi, M.; Tsuchida, K.; Takemoto, Y.; Kawahito, Y.; Sano, H.; Nakatani, T. 2005: 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncology Reports 14(1): 73-79

Iikura, M.; Suzukawa, M.; Yamaguchi, M.; Sekiya, T.; Komiya, A.; Yoshimura-Uchiyama, C.; Nagase, H.; Matsushima, K.; Yamamoto, K.; Hirai, K. 2005: 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation. Journal of Allergy and Clinical Immunology 116(3): 578-585

Hennig, R.; Grippo, P.; Ding, X-Zhong.; Rao, S.M.; Buchler, M.W.; Friess, H.; Talamonti, M.S.; Bell, R.H.; Adrian, T.E. 2005: 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. Cancer Research 65(14): 6011-6016

Plante, H.; Picard, S.; Mancini, J.; Borgeat, P. 2005: 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis. Biochemical Journal 393(Pt 1): 211-218

Griffith, T.M.; Chaytor, A.T.; Bakker, L.M.; Edwards, D.H. 2005: 5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation. Proceedings of the National Academy of Sciences of the United States of America 102(19): 7008-7013

Kok, R.M.; Smith, D.E.C.; Dainty, J.R.; Van Den Akker, J.T.; Finglas, P.M.; Smulders, Y.M.; Jakobs, C.; De Meer, K. 2004: 5-Methyltetrahydrofolic acid and folic acid measured in plasma with liquid chromatography tandem mass spectrometry: applications to folate absorption and metabolism. Analytical Biochemistry 326(2): 129-138

Samanta, S.; Srikanth, K.; Banerjee, S.; Debnath, B.; Gayen, S.; Jha, T. 2004: 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological activity and QSAR study. Bioorganic and Medicinal Chemistry 12(6): 1413-1423

Leonard, S.W.; Bruno, R.S.; Paterson, E.; Schock, B.C.; Atkinson, J.; Bray, T.M.; Cross, C.E.; Traber, M.G. 2003: 5-nitro-gamma-tocopherol increases in human plasma exposed to cigarette smoke in vitro and in vivo. Free Radical Biology and Medicine 35(12): 1560-1567

O'Flaherty, J.T.; Rogers, L.C.; Paumi, C.M.; Hantgan, R.R.; Thomas, L.R.; Clay, C.E.; High, K.; Chen, Y.Q.; Willingham, M.C.; Smitherman, P.K.; Kute, T.E.; Rao, A.; Cramer, S.D.; Morrow, C.S. 2005: 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochimica et Biophysica Acta 1736(3): 228-236

Kopka, K.; Faust, A.; Keul, P.; Wagner, S.; Breyholz, H-Jörg.; Höltke, C.; Schober, O.; Schäfers, M.; Levkau, B. 2006: 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis. Journal of Medicinal Chemistry 49(23): 6704-6715

Mosca, L.; Lendaro, E.; d'Erme, M.; Marcellini, S.; Moretti, S.; Rosei, M.Anna. 2006: 5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y. Neurochemistry International 49(3): 262-269

Ballard, P.; Bradbury, R.H.; Hennequin, L.F.A.; Hickinson, D.Mark.; Johnson, P.D.; Kettle, J.G.; Klinowska, T.; Morgentin, R.; Ogilvie, D.J.; Olivier, A. 2005: 5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic and Medicinal Chemistry Letters 15(19): 4226-4229

Gu, F.; Netscher, T.; Atkinson, J. 2006: 5-Trideuteromethyl-alpha-tocotrienol and 5-(CH3)-C-14-alpha-tocotrienol as biological tracers of tocotrienols. Journal of Labelled Compounds and Radiopharmaceuticals 49(8): 733-743

Whitley, H.P.; Fermo, J.D.; Chumney, E.C.G. 2006: 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease. PharmacoTherapy 26(5): 682-688

Jonasson, F.; Arnarsson, A.; Peto, T.; Sasaki, H.; Sasaki, K.; Bird, A.C. 2005: 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 112(1): 132-138

Boyle, P.; Roehrborn, C.; Harkaway, R.; Logie, J.; de la Rosette, J.; Emberton, M. 2004: 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. European Urology 45(5): 620-6; Discussion 626-7

Batt, D.G.; Qiao, J.X.; Modi, D.P.; Houghton, G.C.; Pierson, D.A.; Rossi, K.A.; Luettgen, J.M.; Knabb, R.M.; Jadhav, P.K.; Wexler, R.R. 2004: 5-Amidinoindoles as dual inhibitors of coagulation factors IXa and Xa. Bioorganic and Medicinal Chemistry Letters 14(21): 5269-5273

Qian-Li-Ping; Lin-Geng-Jin; Xu-San-Rong 2004: 5-amino salicylic acid enteric-coated tablet in treatment of ulcerative colitis. Zhongguo Xinyao yu Linchuang Zazhi 23(10): 702-705

Distrutti, E.; Sediari, L.; Mencarelli, A.; Renga, B.; Orlandi, S.; Russo, G.; Caliendo, G.; Santagada, V.; Cirino, G.; Wallace, J.L.; Fiorucci, S. 2006: 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. Journal of Pharmacology and Experimental Therapeutics 319(1): 447-458

Guigas, B.; Bertrand, L.; Taleux, N.; Foretz, M.; Wiernsperger, N.; Vertommen, D.; Andreelli, F.; Viollet, B.; Hue, L. 2006: 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55(4): 865-874

Gaidhu, M.Pinky.; Fediuc, S.; Ceddia, R.Bacis. 2006: 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. Journal of Biological Chemistry 281(36): 25956-25964

Jung, J.Eun.; Lee, J.; Ha, J.; Kim, S.Soo.; Cho, Y.Ho.; Baik, H.Hwan.; Kang, I. 2004: 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neuroscience Letters 354(3): 197-200

Babjuk, M.; Soukup, V.; Petrík, R.; Jirsa, M.; Dvorácek, J. 2005: 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Bju International 96(6): 798-802

Fotinos, N.; Campo, M.A.; Popowycz, F.; Gurny, R.; Lange, N. 2006: 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochemistry and Photobiology 82(4): 994-1015

Ding, L.; Xu, R.; Jiang, X.; Chen, Z.; Cai, Y.; Zou, Y.; Du, M. 2004: 5-aminolevulinic acid-mediated photodynamic therapy of human glioma cells in vitro. Chinese Journal of Clinical Oncology 31(4): 256-261

van Staa, T.P.; Card, T.; Logan, R.F.; Leufkens, H.G.M. 2005: 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54(11): 1573-1578

Brunner, M.; Lackner, E.; Exler, P.S.; Fluiter, H.C.; Kletter, K.; Tschurlovits, M.; Dudczak, R.; Eichler, H-G.; Müller, M. 2006: 5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers. Alimentary Pharmacology and Therapeutics 23(1): 137-144

Van Staa, T.P.; Travis, S.; Leufkens, H.G.M.; Logan, R.F. 2004: 5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study. Gastroenterology 126(7): 1733-1739

Stickney, D.R.; Dowding, C.; Garsd, A.; Ahlem, C.; Whitnall, M.; McKeon, M.; Reading, C.; Frincke, J. 2006: 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression. International Immunopharmacology 6(11): 1706-1713

Rizzetto, E.; Castellano, S.; Florio, C.; Vadori, M.; Stefancich, G. 2006: 5-aryl-imidazo[2,1-c][1,4]benzodiazepine derivatives as tricyclic constrained analogues of diazepam and Ro5-4864. Synthesis and binding properties at peripheral and central benzodiazepine receptors. Die Pharmazie 61(6): 505-510

Bang, S-Cheol.; Kim, Y.; Yun, M-Young.; Ahn, B-Zun. 2004: 5-Arylidene-2(5H)-furanone derivatives: synthesis and structure-activity relationship for cytotoxicity. Archives of Pharmacal Research 27(5): 485-494

Ottanà, R.; Maccari, R.; Barreca, M.Letizia.; Bruno, G.; Rotondo, A.; Rossi, A.; Chiricosta, G.; Di Paola, R.; Sautebin, L.; Cuzzocrea, S.; Vigorita, M.Gabriella. 2005: 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorganic and Medicinal Chemistry 13(13): 4243-4252

Fulda, S.; Debatin, K.M. 2006: 5-aza-2 '-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 25(37): 5125-5133

Fang, J-yuan.; Yang, L.; Zhu, H-yin.; Chen, Y-xuan.; Lu, J.; Lu, R.; Cheng, Z-hua.; Xiao, S-dong. 2004: 5-Aza-2'-deoxycitydine induces demethylation and up-regulates transcription of p16INK4A gene in human gastric cancer cell lines. Chinese Medical Journal 117(1): 99-103

Tachibana, K.; Takeda, K.; Shiraishi, M. 2004: 5-aza-2'-deoxycytidine reactivates the CDH1 gene without influencing methylation of the entire CpG island or histone modification in a human cancer cell line. Proceedings of the Japan Academy B Physical and Biological Sciences 80(7): 342-348

Suzuki, M.; Harashima, A.; Okochi, A.; Yamamoto, M.; Nakamura, S.; Motoda, R.; Yamasaki, F.; Orita, K. 2004: 5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells. American Journal of Hematology 77(3): 313-315

Kim, D.; Min, J.; Ahn, S.Kil.; Lee, H.Woo.; Choi, N.Song.; Moon, S.Kee. 2004: 5-demethoxyfumagillol, a potent angiogenesis inhibitor isolated from Aspergillus fumigatus. Chemical and Pharmaceutical Bulletin 52(4): 447-450

Parsels, L.Anne.; Parsels, J.David.; Tai, D.Chung-Ho.; Coughlin, D.James.; Maybaum, J. 2004: 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells. Cancer Research 64(18): 6588-6594

Wellington, M.; Kabir, M.Anaul.; Rustchenko, E. 2006: 5-fluoro-orotic acid induces chromosome alterations in genetically manipulated strains of Candida albicans. Mycologia 98(3): 393-398

Huang, X.W.; Tang, Z.Y.; Lawrence, T.S.; Zhang, M. 2004: 5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells. Journal of Cancer Research and Clinical Oncology 131(3): 184-190

Fang, F.; Hoskins, J.; Butler, J.Scott. 2004: 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Molecular and Cellular Biology 24(24): 10766-10776

Takamori, H.; Kanemitsu, K.; Tsuji, T.; Tanaka, H.; Chikamoto, A.; Nakahara, O.; Hiraoka, T.; Ikeda, O.; Kudo, K.; Imuta, M.; Yamashita, Y. 2005: 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer. Pancreas 30(3): 223-226

Fakih, M.G. 2004: 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction. Oncology 67(3-4): 222-224

Matsumura, Y.; Yashiro, M.; Ohira, M.; Tabuchi, H.; Hirakawa, K. 2005: 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells. Anticancer Research 25(5): 3271-3278

Morganti, A.G.; Valentini, V.; Macchia, G.; Mattiucci, G.Carlo.; Costamagna, G.; Deodato, F.; Smaniotto, D.; Luzi, S.; Balducci, M.; Barbi, S.; Perri, V.; Trodella, L.; Cellini, N. 2004: 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study. International Journal of Radiation Oncology Biology Physics 59(5): 1454-1460

Correale, P.; Del Vecchio, M.Teresa.; Di Genova, G.; Savellini, G.Gori.; La Placa, M.; Terrosi, C.; Vestri, M.; Urso, R.; Lemonnier, F.; Aquino, A.; Bonmassar, E.; Giorgi, G.; Francini, G.; Cusi, M.Grazia. 2005: 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine. Journal of the National Cancer Institute 97(19): 1437-1445

Cho, K-Hyun.; Choi, S-Min.; Kim, B-Chae.; Lee, S-Han.; Park, M-Seok.; Kim, M-Kyu.; Kim, J-Keun. 2004: 5-fluorouracil-induced oligodendrocyte death and inhibitory effect of cycloheximide, Trolox, and Z-VAD-FMK in murine cortical culture. Cancer 100(7): 1484-1490

Boyer, J.; Maxwell, P.J.; Longley, D.B.; Johnston, P.G. 2004: 5-Fluorouracil: identification of novel downstream mediators of tumour response. Anticancer Research 24(2a): 417-423

Serrats, J.; Raurich, A.; Vilaró, M.Teresa.; Mengod, G.; Cortés, R. 2003: 5-ht5B receptor mRNA in the raphe nuclei: coexpression with serotonin transporter. Synapse 51(2): 102-111

Di-Nunno, L.; Scilimati, A.; Vitale, P. 2005: 5-hydroxy-3-phenyl-5-vinyl-2-isoxazoline and 3-phenyl-5-vinylisoxazole: synthesis and reactivity. Tetrahedron 61(47): 11270-11278

Xiao, D-Qin.; Zhu, J-Xia.; Tang, J-Shi.; Jia, H. 2005: 5-hydroxytryptamine 1A (5-HT1A) but not 5-HT3 receptor is involved in mediating the nucleus submedius 5-HT-evoked antinociception in the rat. Brain Research 1046(1-2): 38-44

Pitchot, W.; Hansenne, M.; Pinto, E.; Reggers, J.; Fuchs, S.; Ansseau, M. 2005: 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry 58(11): 854-858

Matsuoka, T.; Hasuo, H.; Akasu, T. 2004: 5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus. Neuroscience Research 48(3): 229-238

Hardy, A.; Palouzier-Paulignan, B.; Duchamp, A.; Royet, J-P.; Duchamp-Viret, P. 2005: 5-Hydroxytryptamine action in the rat olfactory bulb: in vitro electrophysiological patch-clamp recordings of juxtaglomerular and mitral cells. Neuroscience 131(3): 717-731

Ni, W.; Watts, S.W. 2006: 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clinical and Experimental Pharmacology and Physiology 33(7): 575-583

Kushnir-Sukhov, N.M.; Gilfillan, A.M.; Coleman, J.W.; Brown, J.M.; Bruening, S.; Toth, M.; Metcalfe, D.D. 2006: 5-hydroxytryptamine induces mast cell adhesion and migration. Journal of Immunology 177(9): 6422-6432

Cho, H.-Seok; Choi, S.-Joon; Kim, K.-Jung; Lee, H.-Ho; Kim, S.-Yun; Cho, Y.-Jin; Sung, K.-Wug 2005: 5-hydroxytryptamine inhibits glutamatergic synaptic transmission in rat corticostriatal brain slice. Korean Journal of Physiology and Pharmacology 9(5): 255-262

Dürk, T.; Panther, E.; Müller, T.; Sorichter, S.; Ferrari, D.; Pizzirani, C.; Di Virgilio, F.; Myrtek, D.; Norgauer, J.; Idzko, M. 2005: 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. International Immunology 17(5): 599-606

Terzioğlu, B.; Aypak, C.; Yananli, H.Raci.; Küçükibrahimoğlu, E.; Yurdaydin, C.; Gören, M.Zafer. 2005: 5-hydroxytryptamine release in the anterior hypothalamic and the hippocampal areas of cholestatic rats. Life Sciences 78(10): 1078-1083

Hirth, I.C.; Deitmer, J.W. 2006: 5-Hydroxytryptamine-mediated increase in glutamate uptake by the leech giant glial cell. Glia 54(8): 786-794

Bhattacharya, A.; Schenck, K.W.; Xu, Y-Chang.; Nisenbaum, L.; Galbreath, E.; Cohen, M.L. 2004: 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium. Journal of Pharmacology and Experimental Therapeutics 309(2): 825-832

Caironi, P.; Ichinose, F.; Liu, R.; Jones, R.C.; Bloch, K.D.; Zapol, W.M. 2005: 5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury. American Journal of Respiratory and Critical Care Medicine 172(3): 334-343

Lewis, T.A.; Bayless, L.; Eckman, J.B.; Ellis, J.L.; Grewal, G.; Libertine, L.; Marie Nicolas, J.; Scannell, R.T.; Wels, B.F.; Wenberg, K.; Wypij, D.M. 2004: 5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity. Bioorganic and Medicinal Chemistry Letters 14(9): 2265-2268

Hedi, H.; Norbert, G. 2004: 5-Lipoxygenase Pathway, Dendritic Cells, and Adaptive Immunity. Journal of Biomedicine and Biotechnology 2004(2): 99-105

Ikeda, A.; Sekiguchi, K.; Fujita, K.; Yamadera, H.; Koga, Y. 2005: 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. American Journal of Psychiatry 162(4): 815

Antoniades, C.; Shirodaria, C.; Warrick, N.; Cai, S.; de Bono, J.; Lee, J.; Leeson, P.; Neubauer, S.; Ratnatunga, C.; Pillai, R.; Refsum, H.; Channon, K.M. 2006: 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114(11): 1193-1201

Zarnowski, R.; Suzuki, Y.; Zarnowska, E.D.; Esumi, Y.; Kozubek, A.; Pietr, S.J. 2004: 5-n-alkylresoreinols from the nitrogen-fixing soil bacterium Azotobacter chroococcum Az12. Zeitschrift fuer Naturforschung Section C Journal of Biosciences 59(5-6): 318-320

Sturm, G.J.; Schuligoi, R.; Sturm, E.M.; Royer, J.F.; Lang-Loidolt, D.; Stammberger, H.; Amann, R.; Peskar, B.A.; Heinemann, A. 2005: 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils. Journal of Allergy and Clinical Immunology 116(5): 1014-1019

Stamatiou, P.B.; Chan, C-Chung.; Monneret, G.; Ethier, D.; Rokach, J.; Powell, W.S. 2004: 5-oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte/macrophage colony-stimulating factor from monocytes. Journal of Biological Chemistry 279(27): 28159-28164

Koike, D.; Obinata, H.; Yamamoto, A.; Takeda, S.; Komori, H.; Nara, F.; Izumi, T.; Haga, T. 2006: 5-Oxo-eicosatetraenoic acid-induced chemotaxis: identification of a responsible receptor hGPCR48 and negative regulation by G protein G(12/13). Journal of Biochemistry 139(3): 543-549

Kuduk, S.D.; Di Marco, C.Ng.; Chang, R.K.; Wood, M.R.; Kim, J.J.; Schirripa, K.M.; Murphy, K.L.; Ransom, R.W.; Tang, C.; Torrent, M.; Ha, S.; Prueksaritanont, T.; Pettibone, D.J.; Bock, M.G. 2006: 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists. Bioorganic and Medicinal Chemistry Letters 16(10): 2791-2795

Zhang, Y.; Pavlova, O.A.; Chefer, S.I.; Hall, A.W.; Kurian, V.; Brown, L.L.; Kimes, A.S.; Mukhin, A.G.; Horti, A.G. 2004: 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography. Journal of Medicinal Chemistry 47(10): 2453-2465

Denton, T.T.; Zhang, X.; Cashman, J.R. 2005: 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. Journal of Medicinal Chemistry 48(1): 224-239

Singh, P.; Mittal, A.; Kaur, S.; Kumar, S. 2006: 5-Substituted-2,3-diphenyltetrahydrofurans: a new class of moderately selective COX-2 inhibitors. Bioorganic and Medicinal Chemistry 14(23): 7910-7916

Jaycock, P.D.; O'Brart, D.P.S.; Rajan, M.S.; Marshall, J. 2005: 5-year follow-up of LASIK for hyperopia. Ophthalmology 112(2): 191-199

Fox, K.A.A.; Poole-Wilson, P.; Clayton, T.C.; Henderson, R.A.; Shaw, T.R.D.; Wheatley, D.J.; Knight, R.; Pocock, S.J. 2005: 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366(9489): 914-920

Lagerqvist, B.; Husted, S.; Kontny, F.; Ståhle, E.; Swahn, E.; Wallentin, L. 2006: 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368(9540): 998-1004

Osman, M.M.; Alfano, Y.; Kamp, S.; Haecker, A.; Alken, P.; Michel, M.Stephan.; Knoll, T. 2005: 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. European Urology 47(6): 860-864

Malagoli, D.; Lusvardi, M.; Gobba, F.; Ottaviani, E. 2004: 50 Hz magnetic fields activate mussel immunocyte p38 MAP kinase and induce HSP70 and 90. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 137(1): 75-79

Sommer, A.M.; Lerchl, A. 2006: 50 Hz magnetic fields of 1 mT do not promote lymphoma development in AKR/J mice. Radiation Research 165(3): 343-349

Malagoli, D.; Gobba, F.; Ottaviani, E. 2006: 50 Hz magnetic fields of constant or fluctuating intensity: effects on immunocyte hsp70 in the mussel Mytilus galloprovincialis. Bioelectromagnetics 27(5): 427-429

Capri, M.; Mesirca, P.; Remondini, D.; Carosella, S.; Pasi, S.; Castellani, G.; Franceschi, C.; Bersani, F. 2005: 50 Hz sinusoidal magnetic fields do not affect human lymphocyte activation and proliferation in vitro. Physical Biology 1(3-4): 211-219

Pederson, T. 2005: 50 years ago protein synthesis met molecular biology: the discoveries of amino acid activation and transfer RNA. FASEB Journal 19(12): 1583-1584

Dragesco, J. 1998: 50 years of study in protozoa. Personal experiences. Travaux du Museum National d'Histoire Naturelle "Grigore Antipa" 40: 7-25

Wolf, F.I.; Torsello, A.; Tedesco, B.; Fasanella, S.; Boninsegna, A.; D'Ascenzo, M.; Grassi, C.; Azzena, G.Battista.; Cittadini, A. 2005: 50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: possible involvement of a redox mechanism. Biochimica et Biophysica Acta 1743(1-2): 120-129

Shi, Y.; Bao, X.; Huo, X.; Shen, Z.; Song, T. 2005: 50-Hz magnetic field (0.1-mT) alters c-fos mRNA expression of early post implantation mouse embryos and serum estradiol levels of gravid mice. Birth Defects Research. Part B Developmental and Reproductive Toxicology 74(2): 196-200

Schmitz, C.; Keller, E.; Freuding, T.; Silny, J.; Korr, H. 2003: 50-Hz magnetic field exposure influences DNA repair and mitochondrial DNA synthesis of distinct cell types in brain and kidney of adult mice. Acta Neuropathologica 107(3): 257-264

Hynynen, K.; Clement, G.T.; McDannold, N.; Vykhodtseva, N.; King, R.; White, P.Jason.; Vitek, S.; Jolesz, F.A. 2004: 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magnetic Resonance in Medicine 52(1): 100-107

Du-Puy, David 2004: 506. Aloe compressa Aloaceae. Curtis's Botanical Magazine 21(Part 4): 233, 235-237

Du-Puy, David 2004: 507. Aloe calcairophila Aloaeeae. Curtis's Botanical Magazine 21(Part 4): 238-239, 241

Du-Puy, David 2004: 508. Aloe descoingsii Aloaceae. Curtis's Botanical Magazine 21(Part 4): 242-243, 245

Hardy, D.S. 2004: 509. Dauphinea brevilabra Lainiaceae. Curtis's Botanical Magazine 21(Part 4): 246-247

Association, O.Institutes For Bee Research 2003: 50th Seminar of the Association of Institutes for Bee Research, Schmitten-Arnoldshain, Hesse, Germany, March 25-27, 2003. Apidologie 34(5): 473-510

Hermans, J. 2004: 510. Angraecum praestans Orchidaceae. Curtis's Botanical Magazine 21(Part 4): 248-250

Cribb, P. 2005: 511. Phragmipedium kovachii Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 8-11

Cribb, P. 2005: 512. Paphiopedilum vietnamense Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 12-18

Cribb, P. 2005: 513. Masdevallia idae Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 19-21

Cribb, P. 2005: 514. Masdevallia niesseniae Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 22-24

Duncan, G. 2005: 515. Bartholina burmanniana Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 25-31

Wood, J. 2005: 516. Bulbophyllum echinolabium Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 32-37

Roberts, D., L.; Sayers, B. 2005: 517. Eria sessilifolia Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 38-41

Benimetskaya, L.; Miller, P.; Stein, C.A. 2005: 518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTIC. Oligonucleotides 15(3): 206-214

Hermans, J.; Cribb, P. 2005: 519. Paralophia epiphytica Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 47-52

Frias, R.; Sankari, S.; Westermarck, E. 2004: 51Cr-EDTA absorption blood test: An easy method for assessing small intestinal permeability in dogs. Journal of Veterinary Internal Medicine 18(2): 156-159

Wright, S.M.; Hellmann, D.B.; Ziegelstein, R.C. 2005: 52 precepts that medical trainees and physicians should consider regularly. American Journal of Medicine 118(4): 435-438

Chase, M.W. 2005: 520. Psychopsis limminghei Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 53-55

Pupulin, F. 2005: 521. Trichocentrum dianthum Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 56-62

Oakeley, H. 2005: 522. Anguloa tognettiae Orchidaceae. Curtis's Botanical Magazine 22(Part 1): 63-70

Mochan, T.A.; Venere, M.; DiTullio, R.A.; Halazonetis, T.D. 2003: 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Research 63(24): 8586-8591

Morales, J.C.; Franco, S.; Murphy, M.M.; Bassing, C.H.; Mills, K.D.; Adams, M.M.; Walsh, N.C.; Manis, J.P.; Rassidakis, G.Z.; Alt, F.W.; Carpenter, P.B. 2006: 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America 103(9): 3310-3315

Iwabuchi, K.; Hashimoto, M.; Matsui, T.; Kurihara, T.; Shimizu, H.; Adachi, N.; Ishiai, M.; Yamamoto, K-ichi.; Tauchi, H.; Takata, M.; Koyama, H.; Date, T. 2006: 53BP1 contributes to survival of cells irradiated with X-ray during G1 without Ku70 or Artemis. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 11(8): 935-948

Ward, I.M.; Difilippantonio, S.; Minn, K.; Mueller, M.D.; Molina, J.R.; Yu, X.; Frisk, C.S.; Ried, T.; Nussenzweig, A.; Chen, J. 2005: 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Molecular and Cellular Biology 25(22): 10079-10086

Pryde, F.; Khalili, S.; Robertson, K.; Selfridge, J.; Ritchie, A-Marie.; Melton, D.W.; Jullien, D.; Adachi, Y. 2005: 53BP1 exchanges slowly at the sites of DNA damage and appears to require RNA for its association with chromatin. Journal of Cell Science 118(Pt 9): 2043-2055

Ward, I.M.; Reina-San-Martin, B.; Olaru, A.; Minn, K.; Tamada, K.; Lau, J.S.; Cascalho, M.; Chen, L.; Nussenzweig, A.; Livak, F.; Nussenzweig, M.C.; Chen, J. 2004: 53BP1 is required for class switch recombination. Journal of Cell Biology 165(4): 459-464

Adams, M.M.; Wang, B.; Xia, Z.; Morales, J.C.; Lu, X.; Donehower, L.A.; Bochar, D.A.; Elledge, S.J.; Carpenter, P.B. 2005: 53BP1 oligomerization is independent of its methylation by PRMT1. Cell Cycle 4(12): 1854-1861

Mochan, T.A.; Venere, M.; DiTullio, R.A.; Halazonetis, T.D. 2004: 53BP1, an activator of ATM in response to DNA damage. Dna Repair 3(8-9): 945-952

Kobayashi, S.; Kajino, S.; Takahashi, N.; Kanazawa, S.; Imai, K.; Hibi, Y.; Ohara, H.; Itoh, M.; Okamoto, T. 2005: 53BP2 induces apoptosis through the mitochondrial death pathway. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 10(3): 253-260

Chander, H.; Majumdar, S.; Sapru, S.; Rishi, P. 2006: 55 kDa outer-membrane protein from short-chain fatty acids exposed Salmonella enterica serovar Typhi induces apoptosis in macrophages. Antonie van Leeuwenhoek 89(3-4): 317-323

Anonymous 2004: 55th Starch Convention, Detmold, Germany, April 21-23, 2004. Starch 56(9): 432-447

Campolmi, P.; Mavilia, L.; Bonan, P.; Cannarozzo, G.; Lotti, T.M. 2005: 595 nm pulsed dye laser for the treatment of superficial basal cell carcinoma. Lasers in Medical Science 20(3-4): 147-148

Ochrietor, J.D.; Linser, P.J. 2005: 5A11/Basigin gene products are necessary for proper maturation and function of the retina. Developmental Neuroscience 26(5-6): 380-387

Jain, K.; Roy, U.; Ardelt, B.; Krishna, U.M.; Falck, J.R.; Pozarowski, P.; Kunicki, J.; Darzynkiewicz, Z.; Balazy, M. 2005: 5E, 8Z, 11Z, 14Z-eicosatetraenoic acid, a novel trans isomer of arachidonic acid, causes G1 phase arrest and induces apoptosis of HL-60 cells. International Journal of Oncology 27(5): 1177-1185

Reerink, O.; Mulder, N.H.; Szabo, B.G.; Hospers, G.A.P. 2004: 5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients. Anticancer Research 24(3b): 1969-1971

Harmer, C.J.; Reid, C.B.; Ray, M.Kar.; Goodwin, G.M.; Cowen, P.J. 2006: 5HT(3) antagonism abolishes the emotion potentiated startle effect in humans. Psychopharmacology 186(1): 18-24

Zeinstra, E.M.; Wilczak, N.; Wilschut, J.C.; Glazenburg, L.; Chesik, D.; Kroese, F.G.M.; De Keyser, J. 2006: 5HT4 agonists inhibit interferon-gamma-induced MHC class II and B7 costimulatory molecules expression on cultured astrocytes. Journal of Neuroimmunology 179(1-2): 191-195

Kopczyńska, B.; Szereda-Przestaszewska, Młgorzata. 2004: 5HT2 and 5HT3 receptors' contribution to modeling of post-serotonin respiratory pattern in cats. Life Sciences 75(19): 2281-2290

Radhika, P.; Cabeza, M.; Bratoeff, E.; García, G. 2004: 5alpha-Reductase inhibition activity of steroids isolated from marine soft corals. Steroids 69(7): 439-444

Frye, C.A.; Edinger, K.L.; Seliga, A.M.; Wawrzycki, J.M. 2004: 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology 29(8): 1019-1027

McInnes, K.J.; Kenyon, C.J.; Chapman, K.E.; Livingstone, D.E.W.; Macdonald, L.J.; Walker, B.R.; Andrew, R. 2004: 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. Journal of Biological Chemistry 279(22): 22908-22912

Ribeiro, C.Moreira.; Pereira, O.Câmara.Marques. 2005: 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: reproductive aspects. Pharmacology Biochemistry and Behavior 82(1): 228-235

Todorovic, S.M.; Pathirathna, S.; Brimelow, B.C.; Jagodic, M.M.; Ko, S-Hoon.; Jiang, X.; Nilsson, K.R.; Zorumski, C.F.; Covey, D.F.; Jevtovic-Todorovic, V. 2004: 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo. Molecular Pharmacology 66(5): 1223-1235

Anonymous 2004: 5th Muenster Workshop on Trace Elements and Electrolytes, AKTE 2/2003, Hannover, Germany, November 15, 2003. Trace Elements and Electrolytes 21(4): 281-286

Anonymous 2004: 5th Multidisciplinary Workshop of the Argentine Biology Society, Buenos Aires, Argentina, December 9-10, 2003. Biocell 28(1): 103-123

Lauge-Pedersen, H.; Gustafsson, J.; Hägglund, G. 2006: 6 Weeks with the von Rosen splint is sufficient for treatment of neonatal hip instability. Acta Orthopaedica 77(2): 257-261

Thomas, Aèle.; Ross, R.A.; Saha, B.; Mahadevan, A.; Razdan, R.K.; Pertwee, R.G. 2004: 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. European Journal of Pharmacology 487(1-3): 213-221

Kakar, S.M.; Paine, M.F.; Stewart, P.W.; Watkins, P.B. 2004: 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect. Clinical Pharmacology and Therapeutics 75(6): 569-579

Veleiro, A.S.; Pecci, A.; Monteserín, Mía.C.; Baggio, R.; Garland, Mía.T.; Lantos, C.P.; Burton, G. 2005: 6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity. Journal of Medicinal Chemistry 48(18): 5675-5683

Sato, Y.; Shibata, H.; Arakaki, N.; Higuti, T. 2004: 6,7-dihydroxyflavone dramatically intensifies the susceptibility of methicillin-resistant or -sensitive Staphylococcus aureus to beta-lactams. Antimicrobial Agents and ChemoTherapy 48(4): 1357-1360

Tunali, T.; Yarat, A.; Bulut, M.; Emekli, N. 2004: 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation. British Journal of Haematology 126(2): 226-230

Welte, S.; Baringhaus, K-Heinz.; Schmider, W.; Müller, Günter.; Petry, S.; Tennagels, N. 2005: 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Analytical Biochemistry 338(1): 32-38

Schreiner, E.P.; Wolff, B.; Winiski, A.P.; Billich, A. 2003: 6-(2-Adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: A potent non-steroidal irreversible inhibitor of human steroid sulfatase. Bioorganic and Medicinal Chemistry Letters 13(24): 4313-4316

Kiselgof, E.; Tulshian, D.B.; Arik, L.; Zhang, H.; Fawzi, A. 2005: 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists. Bioorganic and Medicinal Chemistry Letters 15(8): 2119-2122

Ramunno, A.; Dukat, Młgorzata.; Lee, M.; Young, R.; El-Zahabi, M.; Damaj, M.Imad.; Martin, B.; Glennon, R.A. 2005: 6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand. Bioorganic and Medicinal Chemistry Letters 15(13): 3237-3240

Balzarini, J.; Pannecouque, C.; Naesens, L.; Andrei, G.; Snoeck, R.; De-Clercq, E.; Hockova, D.; Holy, A. 2004: 6-(2-phosphonomethoxy)alkoxy)-2,4-diaminopyrimidines: A new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity. Nucleosides Nucleotides and Nucleic Acids 23(8-9): 1321-1327

Tamta, H.; Thilagavathi, R.; Chakraborti, A.K.; Mukhopadhyay, A.K. 2005: 6-(N-benzoylamino)purine as a novel and potent inhibitor of xanthine oxidase: inhibition mechanism and molecular modeling studies. Journal of Enzyme Inhibition and Medicinal Chemistry 20(4): 317-324

Lin, C-Mao.; Huang, S-Tung.; Lee, F-Wei.; Kuo, H-Saw.; Lin, M-Hsiang. 2006: 6-Acyl-4-aryl/alkyl-5,7-dihydroxycoumarins as anti-inflammatory agents. Bioorganic and Medicinal Chemistry 14(13): 4402-4409

Ulven, T.; Little, P.Brian.; Receveur, J-Marie.; Frimurer, T.M.; Rist, O.; Nørregaard, P.K.; Högberg, T. 2006: 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: Structure-activity exploration of eastern and western parts. Bioorganic and Medicinal Chemistry Letters 16(4): 1070-1075

Ulven, T.; Frimurer, T.M.; Receveur, J-Marie.; Little, P.Brian.; Rist, O.; Nørregaard, P.K.; Högberg, T. 2005: 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode. Journal of Medicinal Chemistry 48(18): 5684-5697

Sbardella, G.; Bartolini, S.; Castellano, S.; Artico, M.; Paesano, N.; Rotili, D.; Spadafora, C.; Mai, A. 2006: 6-alkylthio-4-[1-(2,6-difluorophenyl)alkyl]-1H-[1,3,5]triazin-2-ones (ADATs): novel regulators of cell differentiation and proliferation. Chemmedchem 1(10): 1073-1080

Satoh, T.; Kano, H.; Nakatani, M.; Sakairi, N.; Shinkai, S.; Nagasaki, T. 2006: 6-Amino-6-deoxy-chitosan. Sequential chemical modifications at the C-6 positions of N-phthaloyl-chitosan and evaluation as a gene carrier. Carbohydrate Research 341(14): 2406-2413

Viola, G.; Facciolo, L.; Dall'Acqua, S.; Di Lisa, F.; Canton, M.; Vedaldi, D.; Fravolini, A.; Tabarrini, O.; Cecchetti, V. 2004: 6-Aminoquinolones: photostability, cellular distribution and phototoxicity. Toxicology in Vitro: An International Journal Published in Association with Bibra 18(5): 581-592

Costi, R.; Di Santo, R.; Artico, M.; Roux, A.; Ragno, R.; Massa, S.; Tramontano, E.; La Colla, M.; Loddo, R.; Marongiu, M.Elena.; Pani, A.; La Colla, P. 2004: 6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays. Bioorganic and Medicinal Chemistry Letters 14(7): 1745-1749

Sharon, A.; Pratap, R.; Vatsyayan, R.; Maulik, P.R.; Roy, U.; Goel, A.; Ram, V.Ji. 2005: 6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-gamma activators. Bioorganic and Medicinal Chemistry Letters 15(14): 3356-3360

Park, H.Joo.; Kim, Y-Shin.; Kim, J.Sung.; Lee, E-Jin.; Yi, Y-Jin.; Hwang, H.Jin.; Suh, M-Eun.; Ryu, C-Kyu.; Lee, S.Kook. 2004: 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents. Bioorganic and Medicinal Chemistry Letters 14(13): 3385-3388

Maslen, H.L.; Hughes, D.; Hursthouse, M.; De Clercq, E.; Balzarini, J.; Simons, C. 2004: 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains. Journal of Medicinal Chemistry 47(22): 5482-5491

Glocke, P.; Collins, G.; Sedgley, M. 2006: 6-Benzylamino purine stimulates in vitro shoot organogenesis in Eucalyptus erythronema, E. stricklandii and their interspecific hybrids. Scientia Horticulturae 109(4): 339-344

Hashimoto, Y.; Miyakawa, H.; Kudo, Y.; Inoue, M. 2004: 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) increases GABAA receptor-mediated spontaneous postsynaptic currents in the dentate granule cells of rat hippocampal slices. Neuroscience Letters 358(1): 33-36

Katoh, M.; Araki, A.; Ogura, T.; Valdivia, R.P.A. 2004: 6-Dimethylaminopurine (6-DMAP), which is used to produce most cloned animals, is mutagenic in Salmonella typhimurium TA1535. Mutation Research 560(2): 199-201

Kuhad, A.; Tirkey, N.; Pilkhwal, S.; Chopra, K. 2006: 6-Gingerol prevents cisplatin-induced acute renal failure in rats. Biofactors 26(3): 189-200

Schott, Y.; Decker, M.; Rommelspacher, H.; Lehmann, J. 2006: 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors. Bioorganic and Medicinal Chemistry Letters 16(22): 5840-5843

Sperlinga, E.; Kosson, P.; Urbanczyk-Lipkowska, Z.; Ronsisvalle, G.; Carr, D.B.; Lipkowski, A.W. 2005: 6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid mimics active conformation of tyrosine in opioid peptides. Bioorganic and Medicinal Chemistry Letters 15(10): 2467-2469

Cohen, J.; Paul, G.K.; Gunasekera, S.P.; Longley, R.E.; Pomponi, S.A. 2004: 6-Hydroxydiscodermindole, a new discodermindole from the marine sponge Discodermia polydiscus. Pharmaceutical Biology 42(1): 59-61

Carvey, P.M.; Zhao, C.H.; Hendey, B.; Lum, H.; Trachtenberg, J.; Desai, B.S.; Snyder, J.; Zhu, Y.G.; Ling, Z.D. 2005: 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. European Journal of Neuroscience 22(5): 1158-1168

Zhang, J.; Hu, J.; Ding, J-Hua.; Yao, H-Hong.; Hu, G. 2005: 6-Hydroxydopamine-induced glutathione alteration occurs via glutathione enzyme system in primary cultured astrocytes. Acta Pharmacologica Sinica 26(7): 799-805

Kondoh, T.; Bannai, M.; Nishino, H.; Torii, K. 2005: 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging. Experimental Neurology 192(1): 194-202

Maharaj, D.S.; Walker, R.B.; Glass, B.D.; Daya, S. 2003: 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates. Journal of Chemical Neuroanatomy 26(2): 103-107

Maharaj, D.S.; Maharaj, H.; Antunes, E.M.; Maree, D.M.; Nyokong, T.; Glass, B.D.; Daya, S. 2005: 6-Hydroxymelatonin protects against quinolinic-acid-induced oxidative neurotoxicity in the rat hippocampus. Journal of Pharmacy and Pharmacology 57(7): 877-881

Tobrman, Tás.; Dvorák, D. 2003: 6-Magnesiated purines: preparation and reaction with aldehydes. Organic Letters 5(23): 4289-4291

Domènech, E.; Nos, P.; Papo, M.; López-San Román, A.; Garcia-Planella, E.; Gassull, M.A. 2005: 6-Mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine. Scandinavian Journal of Gastroenterology 40(1): 52-55

Vázquez, M.Eugenio.; Blanco, J.B.; Salvadori, S.; Trapella, C.; Argazzi, R.; Bryant, S.D.; Jinsmaa, Y.; Lazarus, L.H.; Negri, L.; Giannini, E.; Lattanzi, R.; Colucci, M.; Balboni, G. 2006: 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. Journal of Medicinal Chemistry 49(12): 3653-3658

Yamaguchi, M.; Ishida, H.; Kanamori, A.; Kannagi, R.; Kiso, M. 2005: 6-O-sulfo sialylparagloboside and sialyl Lewis X neo-glycolipids containing lactamized neuraminic acid: synthesis and antigenic reactivity against G159 monoclonal antibody. Glycoconjugate Journal 22(3): 95-108

Cao, L-Wei.; Wang, H.; Li, J-Shu.; Zhang, H-Shan. 2005: 6-Oxy-(N-succinimidyl acetate)-9-(2'-methoxycarbonyl)fluorescein as a new fluorescent labeling reagent for aliphatic amines in environmental and food samples using high-performance liquid chromatography. Journal of Chromatography A 1063(1-2): 143-151

Durì, L.; Morelli, C.F.; Crippa, S.; Speranza, G. 2004: 6-Phenylpyrones and 5-methylchromones from Kenya aloe. Fitoterapia 75(5): 520-522

Obach, Mè.; Navarro-Sabaté, A.; Caro, J.; Kong, X.; Duran, J.; Gómez, M.; Perales, J.Carlos.; Ventura, F.; Rosa, J.Luis.; Bartrons, R. 2004: 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. Journal of Biological Chemistry 279(51): 53562-53570

Chevalier, N.; Bertrand, L.; Rider, M.H.; Opperdoes, F.R.; Rigden, D.J.; Michels, P.A.M. 2005: 6-Phosphofructo-2-kinase and fructose-2,6-bisphosphatase in Trypanosomatidae. Molecular characterization, database searches, modelling studies and evolutionary analysis. Febs Journal 272(14): 3542-3560

Demos, M.K.; Waters, P.J.; Vallance, H.D.; Lillquist, Y.; Makhseed, N.; Hyland, K.; Blau, N.; Connolly, M.B. 2005: 6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia. Annals of Neurology 58(1): 164-167

Kong, J.Sun.; Kang, J-Youn.; Kim, H.Lim.; Kwon, O-Seob.; Lee, K.Ho.; Park, Y.Shik. 2006: 6-Pyruvoyltetrahydropterin synthase orthologs of either a single or dual domain structure are responsible for tetrahydrobiopterin synthesis in bacteria. Febs Letters 580(20): 4900-4904

Fujieda, N.; Satoh, A.; Tsuse, N.; Kano, K.; Ikeda, T. 2004: 6-S-cysteinyl flavin mononucleotide-containing histamine dehydrogenase from Nocardioides simplex: molecular cloning, sequencing, overexpression, and characterization of redox centers of enzyme. Biochemistry 43(33): 10800-10808

Kyung, K.Soo.; Gon, J.Hyo.; Geun, K.Yong.; Sup, J.Jin.; Suk, W.Jae.; Ho, K.Jae. 2006: 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. European Journal of Neuroscience 24(4): 1042-1052

Kalman, T.I.; Lai, L. 2005: 6-Substituted 5-fluorouracil derivatives as transition state analogue inhibitors of thymidine phosphorylase. Nucleosides Nucleotides and Nucleic Acids 24(5-7): 367-373

de Boer, N.K.H.; Van Elburg, R.M.; Wilhelm, A.J.; Remmink, A.J.; Van Vugt, J.M.G.; Mulder, C.J.J.; Van Bodegraven, A.A. 2005: 6-Thioguanine for Crohn's disease during pregnancy: Thiopurine metabolite measurements in both mother and child. Scandinavian Journal of Gastroenterology 40(11): 1374-1377

Roblin, X.; Serre-Debeauvais, F.; Phelip, J-M.; Faucheron, J-L.; Hardy, G.; Chartier, A.; Helluwaert, F.; Bessard, G.; Bonaz, B. 2005: 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine. Alimentary Pharmacology and Therapeutics 21(7): 829-839

Bartolini, S.; Mai, A.; Artico, M.; Paesano, N.; Rotili, D.; Spadafora, C.; Sbardella, G. 2005: 6-[1-(2,6-difluorophenyl)ethyl]pyrimidinones antagonize cell proliferation and induce cell differentiation by inhibiting (a nontelomeric) endogenous reverse transcriptase. Journal of Medicinal Chemistry 48(22): 6776-6778

Engliez, S.-Ahmad; Park, I.-Kook 2005: 6-aminonicotinamide induces G(1) arrest by elevating p27(kip1) as well as inhibiting cdk2, cyclin E and p-Rb in IMR32 neuroblastoma cell line. Integrative Biosciences 9(4): 191-198

Chordia, M.D.; Zigler, M.; Murphree, L.J.; Figler, H.; Macdonald, T.L.; Olsson, R.A.; Linden, J. 2005: 6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency. Journal of Medicinal Chemistry 48(16): 5131-5139

Alves da Costa, C.; Dunys, J.; Brau, Fédéric.; Wilk, S.; Cappai, R.; Checler, Fédéric. 2006: 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. Journal of Biological Chemistry 281(14): 9824-9831

Liang, Q.; Liou, A.K.F.; Ding, Y.; Cao, G.; Xiao, X.; Perez, R.G.; Chen, J. 2004: 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. Journal of Neuroscience Research 77(5): 747-761

Endepols, H.; Schul, J.; Gerhardt, H.Carl.; Walkowiak, W. 2004: 6-hydroxydopamine lesions in anuran amphibians: a new model system for Parkinson's disease?. Journal of Neurobiology 60(4): 395-410

Bradley, K.C.; Haas, A.R.; Meisel, R.L. 2005: 6-Hydroxydopamine lesions in female hamsters (Mesocricetus auratus) abolish the sensitized effects of sexual experience on copulatory interactions with males. Behavioral Neuroscience 119(1): 224-232

Sellings, L.H.L.; Clarke, P.B.S. 2006: 6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity. Synapse 59(6): 374-377

Jin, D.-Qing; Chul-Park, B.; Kim, J.-Ae 2005: 6-hydroxydopamine-induced adaptive increase in GSH is dependent on reactive oxygen species and Ca2+ but not on extracellular signal-regulated kinase in SK-N-SH human neuroblastoma cells. Journal of Applied Pharmacology 13(4): 256-262

D'amico, A.V.; Manola, J.; Loffredo, M.; Renshaw, A.A.; Dellacroce, A.; Kantoff, P.W. 2004: 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292(7): 821-827

Minchenko, H.; Ogura, T.; Opentanova, I.L.; Minchenko, D.O.; Ochiai, A.; Caro, J.; Komisarenko, S.V.; Esumi, H. 2005: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor. Ukrainskii Biokhimicheskii Zhurnal 77(6): 46-50

Rider, M.H.; Bertrand, L.; Vertommen, D.; Michels, P.A.; Rousseau, G.G.; Hue, L. 2004: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochemical Journal 381(Pt 3): 561-579

Kindzelskii, A.L.; Ueki, T.; Michibata, H.; Chaiworapongsa, T.; Romero, R.; Petty, H.R. 2004: 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase form a supramolecular complex in human neutrophils that undergoes retrograde trafficking during pregnancy. Journal of Immunology 172(10): 6373-6381

Bråthe, A.; Gundersen, L-Lotte.; Malterud, K.E.; Rise, F. 2005: 6-substituted purines as inhibitors of 15-lipoxygenase; a structure-activity study. Archiv der Pharmazie 338(4): 159-166

Hopkins, C., R.; Collar, N. 2004: 6-substituted-5H-pyrrolo(2,3-b)pyrazines via palladium-catalyzed heteroannulation from N-(3-chloropyrazin-2-yl)methanesulfonamide and alkynes. Tetrahedron Letters 45(43): 8087-8090

de Boer, N.K.H.; Reinisch, W.; Teml, A.; van Bodegraven, A.A.; Schwab, M.; Lukas, M.; Ochsenkühn, T.; Petritsch, W.; Knoflach, P.; Almer, S.; van der Merwe, S.W.; Herrlinger, K.R.; Seiderer, J.; Vogelsang, H.; Mulder, C.J.J. 2006: 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. Digestion 73(1): 25-31

Harakawa, S.; Inoue, N.; Saito, A.; Doge, F.; Nagasawa, H.; Suzuki, N.; Martin, D.E. 2004: 60 Hz electric field upregulates cytosolic Ca2+ level in mouse splenocytes stimulated by lectin. Bioelectromagnetics 25(3): 204-210

Wollmann, J.Chr 2004: 60 years of sclerosing foam. Phlebologie 33(2): 63-70

Bracken, T.; Senior, R.; Dudman, J. 2005: 60-Hertz electric-field exposures in transmission line towers. Journal of Occupational and Environmental Hygiene 2(9): 444-455

Anonymous 2005: 61-year-old male patient with shortness of breath. Journal of the American College of Cardiology 46(11): CS1-CS4

van Isterdael, C.E.D.; Stilma, J.S.; Bezemer, P.D.; Tijmes, N.T. 2006: 6,220 institutionalised people with intellectual disability referred for visual assessment between 1993 and 2003: overview and trends. British Journal of Ophthalmology 90(10): 1297-1303

McDougall, M.Preston.; Wright, S.M. 2005: 64-channel array coil for single echo acquisition magnetic resonance imaging. Magnetic Resonance in Medicine 54(2): 386-392

Capo, J.; Mandal, P.; Eyyunni, S.; Ahearn, G. 2005: 65Zn2+ transport by lobster hepato-pancreatic baso-lateral membrane vesicles. Journal of Comparative Physiology B Biochemical Systemic and Environmental Physiology uary; 175(1): 13-20

Gundling, F.; Zillinger, C.; Schmidt, T.; Ingrisch, H.; Heitland, W.; Nerlich, A.; Schepp, W. 2005: 67-jahriger patient mit paradoxer diarrhoe und unauffalliger virtueller koloskopie. Zeitschrift fuer Gastroenterologie 43(5): 455-459

Roivainen, A.; Tolvanen, T.; Salomäki, S.; Lendvai, G.; Velikyan, I.; Numminen, P.; Välilä, M.; Sipilä, H.; Bergström, M.; Härkönen, P.; Lönnberg, H.; Långström, B. 2004: 68Ga-labeled oligonucleotides for in vivo imaging with PET. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(2): 347-355

Maecke, H.R.; Hofmann, M.; Haberkorn, U. 2005: (68)Ga-labeled peptides in tumor imaging. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(Suppl): 172s-178s

Zlotos, D.P.; Tränkle, C.; Abdelrahman, A.; Gündisch, D.; Radacki, K.; Braunschweig, H.; Mohr, K. 2006: 6H,13H-Pyrazino[1,2-a;4,5-a']diindole analogs: probing the pharmacophore for allosteric ligands of muscarinic M2 receptors. Bioorganic and Medicinal Chemistry Letters 16(6): 1481-1485

Willkomm, D.K.; Hartmann, R.K. 2005: 6S RNA - an ancient regulator of bacterial RNA polymerase rediscovered. Biological Chemistry 386(12): 1273-1277

Trotochaud, A.E.; Wassarman, K.M. 2004: 6S RNA function enhances long-term cell survival. Journal of Bacteriology 186(15): 4978-4985

Barrick, J.E.; Sudarsan, N.; Weinberg, Z.; Ruzzo, W.L.; Breaker, R.R. 2005: 6S RNA is a widespread regulator of eubacterial RNA polymerase that resembles an open promoter. Rna 11(5): 774-784

Trotochaud, A.E.; Wassarman, K.M. 2006: 6S RNA regulation of pspF transcription leads to altered cell survival at high pH. Journal of Bacteriology 188(11): 3936-3943

Houghton, L.A.; Sherwood, K.L.; Pawlosky, R.; Ito, S.; O'Connor, D.L. 2006: 6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. American Journal of Clinical Nutrition 83(4): 842-850

Kim, S.-Ok; Kundu, J.-Kumar; Shin, Y.-Kee; Park, J.-Hong; Cho, M.-Haing; Kim, T.-Yoon; Surh, Y.-Joon 2005: 6-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappa B in phorbol ester-stimulated mouse skin. Oncogene 24(15): 2558-2567

Elia, M.; Striano, P.; Fichera, M.; Gaggero, R.; Castiglia, L.; Galesi, O.; Malacarne, M.; Pierluigi, M.; Amato, C.; Musumeci, S.A.; Romano, C.; Majore, S.; Grammatico, P.; Zara, F.; Striano, S.; Faravelli, F. 2006: 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases. Epilepsia 47(5): 830-838

Ohata, U.; Hara, H.; Suzuki, H. 2005: 7 cases of hydrofluoric acid burn in which calcium gluconate was effective for relief of severe pain. Contact Dermatitis 52(3): 133-137

Nishiguchi, G.A.; Graham, J.; Bouraoui, A.; Jacobs, R.S.; Little, R.Daniel. 2006: 7,11-epi-thyrsiferol: completion of its synthesis, evaluation of its antimitotic properties, and the further development of an SAR model. Journal of Organic Chemistry 71(16): 5936-5941

Jaiswal, A.S.; Balusu, R.; Narayan, S. 2005: 7,12-Dimethylbenzanthracene-dependent transcriptional regulation of adenomatous polyposis coli (APC) gene expression in normal breast epithelial cells is mediated by GC-box binding protein Sp3. Carcinogenesis 27(2): 252-261

Peltonen, E.; Lukinmaa, P-Liisa.; Sahlberg, C.; Partanen, A-Maija.; Kiukkonen, A.; Alaluusua, S. 2006: 7,12-dimethylbenz[a]anthracene interferes with the development of cultured mouse mandibular molars. Toxicological Sciences: An Official Journal of the Society of Toxicology 92(1): 279-285

Wu, B.; Barrios Sosa, A.Carolina.; Boschelli, D.H.; Boschelli, F.; Honores, E.E.; Golas, J.M.; Powell, D.W.; Wang, Y.D. 2006: 7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups. Bioorganic and Medicinal Chemistry Letters 16(15): 3993-3997

Bonner, L.; Burton, M. 2004: 7-11-year-old children show an advantage for matching and recognizing the internal features of familiar faces: evidence against a developmental shift. Quarterly Journal of Experimental Psychology. A Human Experimental Psychology 57(6): 1019-1029

Sakata, S.; Yamamori, T.; Sakurai, Y. 2005: 7-12 Hz cortical oscillations: behavioral context and dynamics of prefrontal neuronal ensembles. Neuroscience 134(4): 1099-1111

Vodicka, P.Erik.; Linhart, I.; Novak, J.; Koskinen, M.; Vodickova, L.; Hemminki, K. 2005: 7-Alkylguanine adduct levels in urine, lungs and liver of mice exposed to styrene by inhalation. Toxicology and Applied Pharmacology 210(1-2): 1-8

Eriksson, J.; Gharizadeh, B.; Nourizad, N.; Nyrén, Pål. 2004: 7-Deaza-2'-deoxyadenosine-5'-triphosphate as an alternative nucleotide for the pyrosequencing technology. Nucleosides Nucleotides and Nucleic Acids 23(10): 1583-1594

Valencia, A.; Rajadurai, A.; Carle, A.Bjorn.; Kochevar, I.E. 2006: 7-Dehydrocholesterol enhances ultraviolet A-induced oxidative stress in keratinocytes: roles of NADPH oxidase, mitochondria, and lipid rafts. Free Radical Biology and Medicine 41(11): 1704-1718

Mcdonnell, M.E.; Zhang, S.P.; Nasser, N.; Dubin, A.E.; Dax, S.L. 2004: 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1. Bioorganic and Medicinal Chemistry Letters 14(2): 531-534, 19 January

Shimozawa, M.; Naito, Y.; Manabe, H.; Uchiyama, K.; Kuroda, M.; Katada, K.; Yoshida, N.; Yoshikawa, T. 2005: 7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species. Redox Report: Communications in Free Radical Research 9(6): 370-375

Rho, M-Chual.; Kim, Y.Kook.; Chang, J.Sun.; Lee, H.Sun.; Baek, J.Ah.; Chung, M.Yeon.; Lee, H.Cheol.; Lee, H.Woo.; Rhim, B.Yong.; Reidy, M.A.; Kim, K. 2005: 7-Ketocholesterol predisposes human aorta smooth muscle cells to Fas-mediated death. Journal of Molecular and Cellular Cardiology 39(5): 823-832

Girão, H.; Shang, F.; Pereira, P. 2003: 7-ketocholesterol stimulates differentiation of lens epithelial cells. Molecular Vision 9: 497-501

Berthier, A.; Lemaire-Ewing, Séphanie.; Prunet, Céline.; Montange, T.; Vejux, A.; Pais de Barros, J.Paul.; Monier, S.; Gambert, P.; Lizard, Gérard.; Néel, D. 2005: 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. Febs Journal 272(12): 3093-3104

Jang, M.-Hyeon; Shin, M.-Chul; Chang, H.-Kyung; Lee, T.-Hyun; Lee, H.-Hyuk; Shin, M.-Soon; Kim, C.-Ju; Kang, J.-Oh; Hong, S.-Pyo; Cho, S. 2004: 7-Nitroindazole reduces ischemia-induced increment of apoptosis and cell proliferation in the dentate gyrus of rats. Neuroscience Research Communications 35(2): 164-172

Bashkatova, V.; Kraus, M.M.; Vanin, A.; Hornick, A.; Philippu, A.; Prast, H. 2004: 7-nitroindazole, nNOS inhibitor, attenuates amphetamine-induced amino acid release and nitric oxide generation but not lipid peroxidation in the rat brain. Journal of Neural Transmission 112(6): 779-788

Chu, E.; Chu, J.; Socci, R.R.; Chu, T-Ching. 2004: 7-OH-DPAT-induced inhibition of norepinephrine release in PC12 cells. Pharmacology 70(3): 130-139

Hwang, E.-Il; Yun, B.-Sik; Lee, S.-Ran; Kim, S.-Kie; Lim, S.-Jin; Kim, S.-Uk 2004: 7-Oxostaurosporine selectively inhibits the mycelial form of Candida albicans. Journal of Microbiology and Biotechnology 14(5): 1067-1070

Boschelli, D.H.; Wang, Y.D.; Johnson, S.; Wu, B.; Ye, F.; Barrios Sosa, A.Carolina.; Golas, J.M.; Boschelli, F. 2004: 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases. Journal of Medicinal Chemistry 47(7): 1599-1601

Chang, J-Yang.; Hsieh, H-Pang.; Chang, C-Yen.; Hsu, K-Shun.; Chiang, Y-Fang.; Chen, C-Ming.; Kuo, C-Chuan.; Liou, J-Ping. 2006: 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. Journal of Medicinal Chemistry 49(23): 6656-6659

Ribas, J.; Bettayeb, K.; Ferandin, Y.; Knockaert, M.; Garrofe-Ochoa, X.; Totzke, F.; Schachtele, C.; Mester, J.; Polychronopoulos, P.; Magiatis, P.; Skaltsounis, A. , L.; Boix, J.; Meijer, L. 2006: 7-bromoindirubin-3 '-oxime induces caspase-independent cell death. Oncogene 25(47): 6304-6318

Gisbert, J.P.; Fuentes, J.; Carpio, D.; Tito, L.; Guardiola, J.; Tomas, A.; Olivares, D.; Calvet, X. 2005: 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Alimentary Pharmacology and Therapeutics 21(10): 1249-1253

Antos, D.; Schneider-Brachert, W.; Bästlein, E.; Hänel, C.; Haferland, C.; Buchner, M.; Meier, E.; Trump, F.; Stolte, M.; Lehn, N.; Bayerdörffer, E. 2006: 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter 11(1): 39-45

Seela, F.; Peng, X.; Ming, X. 2005: 7-deazapurin-2,6-diamine and 7-deazaguanine: Synthesis and property of 7-substituted nucleosides and oligonucleotides. Nucleosides Nucleotides and Nucleic Acids 24(5-7): 839-841

Vejux, A.; Kahn, E.; Dumas, D.; Bessède, G.; Ménétrier, F.; Athias, A.; Riedinger, J-Marc.; Frouin, Fédérique.; Stoltz, J-François.; Ogier-Denis, E.; Todd-Pokropek, A.; Lizard, Gérard. 2005: 7-Ketocholesterol favors lipid accumulation and colocalizes with Nile Red positive cytoplasmic structures formed during 7-ketocholesterol-induced apoptosis: analysis by flow cytometry, FRET biphoton spectral imaging microscopy, and subcellular fractionation. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 64(2): 87-100

Martinet, W.; De Bie, M.; Schrijvers, D.M.; De Meyer, G.R.Y.; Herman, A.G.; Kockx, M.M. 2004: 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 24(12): 2296-2301

Seye, C.I.; Knaapen, M.W.M.; Daret, Dèle.; Desgranges, C.; Herman, A.G.; Kockx, M.M.; Bult, H. 2004: 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling. Cardiovascular Research 64(1): 144-153

Manzanedo, C.; Aguilar, Mía.A.; Rodríguez-Arias, M.; Navarro, M.; Miñarro, Jé. 2004: 7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine. Behavioural Brain Research 150(1-2): 73-82

Luszczki, J.J.; Sacharuk, A.; Wojciechowska, A.; Andres-Mach, M.M.; Dudra-Jastrzebska, M.; Mohamed, M.; Sawicka, K.M.; Kozinska, J.; Czuczwar, Sław.J. 2006: 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacological Reports: Pr 58(5): 660-671

Luszczki, J.J.; Czuczwar, M.; Gawlik, P.; Sawiniec-Pozniak, G.; Czuczwar, K.; Czuczwar, S.J. 2006: 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Journal of Neural Transmission 113(9): 1157-1168

Park, C.; Cho, K.; Ryu, J.Hoon.; Shin, K.Soon.; Kim, J.; Ahn, H.; Huh, Y. 2004: 7-Nitroindazole upregulates phosphorylated cAMP response element binding protein, polysialylated-neural cell adhesion molecule and tryptophan hydroxylase expression in the adult rat hippocampus. Brain Research 1008(1): 120-125

Lin, W.; Xu, K.; Seela, F. 2005: 7-substituted 8-aza-7-deazapurines and 2,8-diaza-7-deaza-purines: Synthesis of nucleosides and oligonucleotides. Nucleosides Nucleotides and Nucleic Acids 24(5-7): 869-873

Herrmann, N. 2006: 7.Beitrag zur Wuchsform und Biologie der Gefa Bpflanzen des hercynischen Raumes: Bupleurum virgatum Cav. (B.gerardii auct.; Apiaceae). HERCYNIA 39(1): 89-119

Bogart, J.A.; Herndon, J.E.; Lyss, A.P.; Watson, D.; Miller, A.A.; Lee, M.E.; Turrisi, A.T.; Green, M.R. 2004: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. International Journal of Radiation Oncology Biology Physics 59(2): 460-468

Ganswindt, U.; Paulsen, F.; Anastasiadis, A.G.; Stenzl, A.; Bamberg, M.; Belka, C. 2005: 70 Gy or more: which dose for which prostate cancer?. Journal of Cancer Research and Clinical Oncology 131(7): 407-419

Guinez, Céline.; Lemoine, Jérôme.; Michalski, J-Claude.; Lefebvre, T. 2004: 70-kDa-heat shock protein presents an adjustable lectinic activity towards O-linked N-acetylglucosamine. Biochemical and Biophysical Research Communications 319(1): 21-26

Schoeffler, J.Megan.; Rice, D.A.K.; Gresham, D.G. 2005: 70/30 insulin algorithm versus sliding scale insulin. Annals of PharmacoTherapy 39(10): 1606-1610

Miyazaki, T.; Sagawa, R.; Honma, T.; Noguchi, S.; Harada, T.; Komatsuda, A.; Ohtani, H.; Wakui, H.; Sawada, K-Ichi.; Otaka, M.; Watanabe, S.; Jikei, M.; Ogawa, N.; Hamada, F.; Itoh, H. 2004: 73-kDa molecular chaperone HSP73 is a direct target of antibiotic gentamicin. Journal of Biological Chemistry 279(17): 17295-17300

Karnaukhov, V.N. 1999: 75 years since the publication of the book by A.L. Chizhevskii physical factors and the historical process. Biofizika 44(5): 945-952

Liu, T.; Young, G.; Huang, L.; Chen, N-Kuei.; Wong, S.T.C. 2006: 76-space analysis of grey matter diffusivity: methods and applications. Medical Image Computing and Computer-Assisted Intervention: Miccai .. International Conference on Medical Image Computing and Computer-Assisted Intervention 8(Pt 1): 148-155

Drebber, U.; Kasper, H. , U.; Odenthal, M.; Kern, M.A.; Feigk, B.; Dippold, W.G.; Dienes, H.P. 2006: 77-jahriger Patient mit Epstein-Barr-Virus-Erstinfektion mit B-Symptomatik und Hepatitis- ein Fallbericht. Zeitschrift fuer Gastroenterologie 44(5): 387-390

González-Noriega, A.; Ortega Cuellar, D.D.; Michalak, C. 2006: 78 kDa receptor for Man6P-independent lysosomal enzyme targeting: biosynthetic transport from endoplasmic reticulum to "high-density vesicles". Experimental Cell Research 312(7): 1065-1078

Garrido, G.; Sanchez, B.; Rodriguez, H.Maria.; Lorenzano, P.; Alonso, D.; Fernandez, L.Enrique. 2004: 7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies. Hybridoma and Hybridomics 23(3): 168-175

Todorovic, D.; Popovic, D.; Djuric, G.; Radenkovic, M. 2004: 7Be to 210Pb concentration ratio in ground level air in Belgrade area. Journal of Environmental Radioactivity 79(3): 297-307

Yue, Y.; Haaf, T. 2005: 7E olfactory receptor gene clusters and evolutionary chromosome rearrangements. Cytogenetic and Genome Research 112(1-2): 6-10

Vondrácek, J.; Svihálková-Sindlerová, L.; Pencíková, K.; Krcmár, P.; Andrysík, Z.; Chramostová, K.; Marvanová, S.; Valovicová, Z.; Kozubík, A.; Gábelová, A.; Machala, M. 2006: 7H-Dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells. Mutation Research 596(1-2): 43-56

Onafuwa-Nuga, A.A.; Telesnitsky, A.; King, S.R. 2006: 7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles. Rna 12(4): 542-546

Kopecky-Bromberg, S.A.; Martinez-Sobrido, L.; Palese, P. 2005: 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. Journal of Virology 80(2): 785-793

Cook, C.Edgar.; Kepler, J.A. 2005: 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties. Bioorganic and Medicinal Chemistry Letters 15(4): 1213-1216

Luyt, L.G.; Bigott, H.M.; Welch, M.J.; Katzenellenbogen, J.A. 2003: 7alpha- and 17alpha-substituted estrogens containing tridentate tricarbonyl rhenium/technetium complexes: synthesis of estrogen receptor imaging agents and evaluation using microPET with technetium-94m. Bioorganic and Medicinal Chemistry 11(23): 4977-4989

Matsunaga, M.; Ukena, K.; Baulieu, E-Emile.; Tsutsui, K. 2004: 7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proceedings of the National Academy of Sciences of the United States of America 101(49): 17282-17287

Kim, H.-Kyung; Yang, T.-Ki; Park, M.-Hyun; Lee, J.-Young; Kimm, K.-Chan; Kim, C.-Jin; Hong, S.-Tshool 2005: 7q11 region unrelated to dominantly inherited intracranial aneurysm in Korean families. Korean Journal of Genetics 27(3): 261-266

Valis, L.; Mayer-Enthart, E.; Wagenknecht, H-Achim. 2006: 8-(Pyren-1-yl)-2'-deoxyguanosine as an optical probe for DNA hybridization and for charge transfer with small peptides. Bioorganic and Medicinal Chemistry Letters 16(12): 3184-3187

Suzuki, N.; Aoki, D.; Orikawa, K.; Suzuki, A.; Susumu, N.; Tamada, Y.; Sakayori, M.; Tsukazaki, K.; Mukai, M.; Kikuchi, H.; Ishida, I.; Nozawa, S. 2005: 8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin. Placenta 27(2-3): 333-339

Ghias, K.; Ma, C.; Gandhi, V.; Platanias, L.C.; Krett, N.L.; Rosen, S.T. 2005: 8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma. Molecular Cancer Therapeutics 4(4): 569-577

Krett, N.L.; Davies, K.M.; Ayres, M.; Ma, C.; Nabhan, C.; Gandhi, V.; Rosen, S.T. 2004: 8-amino-adenosine is a potential therapeutic agent for multiple myeloma. Molecular Cancer Therapeutics 3(11): 1411-1420

Havlicek, L.; Fuksova, K.; Krystof, V.; Orsag, M.; Vojtesek, B.; Strnad, M. 2005: 8-Azapurines as new inhibitors of cyclin-dependent kinases. Bioorganic and Medicinal Chemistry 13(18): 5399-5407

Gu, Y-Yan.; Zhang, H-Yu.; Zhang, H-Jun.; Li, S-Yan.; Ni, J-Hua.; Jia, H-Ti. 2006: 8-Chloro-adenosine inhibits growth at least partly by interfering with actin polymerization in cultured human lung cancer cells. Biochemical Pharmacology 72(5): 541-550

Ahn, Y-Ho.; Jung, J.Mok.; Hong, S.Hwan. 2004: 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: protein kinase C activation and cyclin B down-regulation. Journal of Cellular Physiology 201(2): 277-285

Lee, B.C.; Choe, Y.S.; Chi, D.Y.; Paik, J.-Y.; Lee, K.-H.; Choi, Y.; Kim, B.-T. 2004: 8-cyclopentadienyltricarbonyl 99mtc 8-oxooctanoic acid: a novel radiotracer for evaluation of medium chain fatty acid metabolism in the liver. Bioconjugate Chemistry 15(1): 121-127

Mignon, L.J.; Wolf, W.A. 2005: 8-Hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease. Neuroreport 16(7): 699-703

Schulpis, K.H.; Papassotiriou, I.; Tsakiris, S. 2006: 8-Hydroxy-2-desoxyguanosine serum concentrations as a marker of DNA damage in patients with classical galactosaemia. Acta Paediatrica 95(2): 164-169

Xi, Z-Ge.; Chao, F-Huan.; Yang, D-Feng.; Zhang, H-Shan.; Zhang, W. 2005: 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage induced by environmental tobacco side-stream smoke and its mechanism. Biomedical and Environmental Sciences: Bes 18(1): 43-47

Jałoszyński, Pł.; Masutani, C.; Hanaoka, F.; Perez, A.Blanco.; Nishimura, S. 2003: 8-Hydroxyguanine in a mutational hotspot of the c-Ha-ras gene causes misreplication, 'action-at-a-distance' mutagenesis and inhibition of replication. Nucleic Acids Research 31(21): 6085-6095

Goswami, A.; Singh, A.K.; Venkataramani, B. 2008: 8-Hydroxyquinoline anchored to silica gel via new moderate size linker: synthesis and applications as a metal ion collector for their flame atomic absorption spectrometric determination. Talanta 60(6): 1141-1154

Farruggia, G.; Iotti, S.; Prodi, L.; Montalti, M.; Zaccheroni, N.; Savage, P.B.; Trapani, V.; Sale, P.; Wolf, F.I. 2006: 8-hydroxyquinoline derivatives as fluorescent sensors for magnesium in living cells. Journal of the American Chemical Society 128(1): 344-350

Xia, L.; Hu, B.; Jiang, Z.; Wu, Y.; Li, L.; Chen, R. 2005: 8-Hydroxyquinoline-chloroform single drop microextraction and electrothermal vaporization ICP-MS for the fractionation of aluminium in natural waters and drinks. Journal of Analytical Atomic Spectrometry 20(5): 441-446

Abou-Raya, A.; El-Hallous, D.; Fayed, H. 2004: 8-Isoprostaglandin F2 alpha: a potential index of lipid peroxidation in systemic lupus erythematosus. Clinical and Investigative Medicine 27(6): 306-311

Scholz, H.; Yndestad, A.; Damås, J.Kristian.; Waehre, T.; Tonstad, S.; Aukrust, Pål.; Halvorsen, B. 2003: 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovascular Research 59(4): 945-954

Carpagnano, G.E.; Kharitonov, S.A.; Resta, O.; Foschino-Barbaro, M.P.; Gramiccioni, E.; Barnes, P.J. 2003: 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4): 1386-1392

Psathakis, K.; Papatheodorou, G.; Plataki, M.; Panagou, P.; Loukides, S.; Siafakas, N.M.; Bouros, D. 2004: 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 125(3): 1005-1011

Yi, S.L.; Kantores, C.; Belcastro, R.; Cabacungan, J.; Tanswell, A.Keith.; Jankov, R.P. 2006: 8-Isoprostane-induced endothelin-1 production by infant rat pulmonary artery smooth muscle cells is mediated by Rho-kinase. Free Radical Biology and Medicine 41(6): 942-949

Virgilio, A.; Esposito, V.; Randazzo, A.; Mayol, L.; Galeone, A. 2005: 8-methyl-2'-deoxyguanosine incorporation into parallel DNA quadruplex structures. Nucleic Acids Research 33(19): 6188-6195

Xu, Y.; Ikeda, R.; Sugiyama, H. 2003: 8-Methylguanosine: a powerful Z-DNA stabilizer. Journal of the American Chemical Society 125(44): 13519-13524

Ma, N.; Tagawa, T.; Hiraku, Y.; Murata, M.; Ding, X.; Kawanishi, S. 2005: 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide: Biology and Chemistry 14(2): 137-143

Ohshima, H.; Sawa, T.; Akaike, T. 2006: 8-nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxidants and Redox Signaling 8(5-6): 1033-1045

Chodoeva, A.; Bosc, J-Jacques.; Guillon, J.; Decendit, A.; Petraud, M.; Absalon, C.; Vitry, C.; Jarry, C.; Robert, J. 2005: 8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities. Bioorganic and Medicinal Chemistry 13(23): 6493-6501

Hedlund, P.B.; Kelly, L.; Mazur, C.; Lovenberg, T.; Sutcliffe, J.Gregor.; Bonaventure, P. 2004: 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. European Journal of Pharmacology 487(1-3): 125-132

Majumdar, D.; Peterson-Ford, A.; Uphouse, L. 2006: 8-OH-DPAT attenuates isoproterenol- but not forskolin-stimulated accumulation of cAMP in mediobasal hypothalamus. Brain Research 1075(1): 93-99

Manuel Apolinar, L.; Meneses, A. 2004: 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behavioural Brain Research 148(1-2): 179-184, 5th January

Gogos, A.; Kusljic, S.; van den Buuse, M. 2005: 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacology Biochemistry and Behavior 81(3): 664-672

Johnson, N.A.; McKenzie, R.; McLean, L.; Sowers, L.C.; Fletcher, H.M. 2004: 8-oxo-7,8-dihydroguanine is removed by a nucleotide excision repair-like mechanism in Porphyromonas gingivalis W83. Journal of Bacteriology 186(22): 7697-7703

Lomax, M.E.; Cunniffe, S.; O'Neill, P. 2004: 8-OxoG retards the activity of the ligase III/XRCC1 complex during the repair of a single-strand break, when present within a clustered DNA damage site. Dna Repair 3(3): 289-299

Kunisada, M.; Sakumi, K.; Tominaga, Y.; Budiyanto, A.; Ueda, M.; Ichihashi, M.; Nakabeppu, Y.; Nishigori, C. 2005: 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis. Cancer Research 65(14): 6006-6010

Kim, J-Eun.; Choi, S.; Yoo, J-Ah.; Chung, M-Hee. 2004: 8-Oxoguanine induces intramolecular DNA damage but free 8-oxoguanine protects intermolecular DNA from oxidative stress. FEBS Letters 556(1-3): 104-110

Li, J-Shu.; Wang, H.; Cao, L-Wei.; Zhang, H-Shan. 2008: 8-Phenyl-(4-oxy-acetic acid N-hydroxysuccinimidyl ester)-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene as a new highly fluorescent-derivatizing reagent for aliphatic amines in disease-related samples with high-performance liquid chromatography. Talanta 69(5): 1190-1199

Heightman, T.D.; Gaster, L.M.; Pardoe, S.L.; Pilleux, J-Pierre.; Hadley, M.S.; Middlemiss, D.N.; Price, G.W.; Roberts, C.; Scott, C.M.; Watson, J.M.; Gordon, L.J.; Holland, V.A.; Powles, J.; Riley, G.J.; Stean, T.O.; Trail, B.K.; Upton, N.; Austin, N.E.; Ayrton, A.D.; Coleman, T.; Cutler, L. 2005: 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands. Bioorganic and Medicinal Chemistry Letters 15(19): 4370-4374

Vangapandu, S.; Sachdeva, S.; Jain, M.; Singh, S.; Singh, P.Pal.; Kaul, C.Lal.; Jain, R. 2003: 8-Quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents. Bioorganic and Medicinal Chemistry 11(21): 4557-4568

Vangapandu, S.; Sachdeva, S.; Jain, M.; Singh, S.; Singh, P.P.; Kaul, C.L.; Jain, R. 2004: 8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities. Bioorganic and Medicinal Chemistry 12(1): 239-247, 2 January

Singer, J.M.; Barr, B.M.; Coughenour, L.L.; Gregory, T.F.; Walters, M.A. 2005: 8-Substituted 3,4-dihydroquinolinones as a novel scaffold for atypical antipsychotic activity. Bioorganic and Medicinal Chemistry Letters 15(20): 4560-4563

Whitehead, J.W.F.; Lee, G.P.; Gharagozloo, P.; Hofer, P.; Gehrig, Aé.; Wintergerst, P.; Smyth, D.; McCoull, W.; Hachicha, M.; Patel, A.; Kyle, D.J. 2005: 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors. Journal of Medicinal Chemistry 48(4): 1237-1243

Wang, M.; Liu, Y.; Liu, S.; Zheng, D. 2004: 8-Chloro-adenosine sensitizes a human hepatoma cell line to TRAIL-induced apoptosis by caspase-dependent and -independent pathways. Oncology Reports 12(1): 193-199

Ahn, Y-Ho.; Jung, J.Mok.; Hong, S.Hwan. 2005: 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells. Cancer Research 65(11): 4896-4901

Zhu, B.; Zhang, L.He.; Zhao, Y.Mei.; Cui, J.Rong.; Strada, S.J. 2005: 8-chloroadenosine induced HL-60 cell growth inhibition, differentiation, and G(0)/G(1) arrest involves attenuated cyclin D1 and telomerase and up-regulated p21(WAF1/CIP1). Journal of Cellular Biochemistry 97(1): 166-177

Chen, S-Sheng.; Huang, W.J.; Chang, L.S.; Wei, Y-Huei. 2004: 8-hydroxy-2'-deoxyguanosine in leukocyte DNA of spermatic vein as a biomarker of oxidative stress in patients with varicocele. Journal of Urology 172(4 Pt 1): 1418-1421

Fujita, T.; Funako, T.; Hayashi, H. 2004: 8-Hydroxydaidzein, an aldose reductase inhibitor from okara fermented with Aspergillus sp. HK-388. Bioscience Biotechnology and Biochemistry 68(7): 1588-1590

Kim, H.Sook.; Ye, S-Kyu.; Cho, I.Hyun.; Jung, J.Eun.; Kim, D-Hyun.; Choi, S.; Kim, Y-Sik.; Park, C-Gyu.; Kim, T-Yoon.; Lee, J.Weon.; Chung, M-Hee. 2006: 8-hydroxydeoxyguanosine suppresses NO production and COX-2 activity via Rac1/STATs signaling in LPS-induced brain microglia. Free Radical Biology and Medicine 41(9): 1392-1403

Nishimura, S. 2006: 8-hydroxyguanine: From its discovery in 1983 to the present status. Proceedings of the Japan Academy B Physical and Biological Sciences 82(4): 127-141

Zeng, H-Ping.; Wang, T-Ting.; Ouyang, X-Hua.; Zhou, Y-Dong.; Jing, H-Lian.; Yuan, G-Zan.; Chen, D-Feng.; Du, S-Hui.; Li, H.; Zhou, J-Hong. 2006: 8-Hydroxyquinoline derivatives induce the proliferation of rat mesenchymal stem cells (rMSCs). Bioorganic and Medicinal Chemistry 14(16): 5446-5450

Zhang, Y.; Pertens, E.; Janssen, L.J. 2005: 8-isoprostaglandin E(2) activates Ca(2+)-dependent K(+) current via cyclic AMP signaling pathway in murine renal artery. European Journal of Pharmacology 520(1-3): 22-28

Scholz, H.; Aukrust, P.; Damås, J.K.; Tonstad, S.; Sagen, E.L.; Kolset, S.O.; Hall, C.; Yndestad, A.; Halvorsen, B. 2004: 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells. European Journal of Clinical Investigation 34(7): 451-458

Schneider, L.A.; Bloch, W.; Kopp, K.; Hainzl, A.; Rettberg, P.; Wlaschek, M.; Horneck, G.; Scharffetter-Kochanek, K. 2006: 8-Isoprostane is a dose-related biomarker for photo-oxidative ultraviolet (UV) B damage in vivo: a pilot study with personal UV dosimetry. British Journal of Dermatology 154(6): 1147-1154

Fortini, P.; Pascucci, B.; Parlanti, E.; D'errico, M.; Simonelli, V.; Dogliotti, E. 2003: 8-oxoguanine DNA damage: At the crossroad of alternative repair pathways. Mutation Research 531(1-2): 127-139

Araneda, S.; Pelloux, S.; Radicella, J.P.; Angulo, J.; Kitahama, K.; Gysling, K.; Forray, M.I. 2005: 8-oxoguanine DNA glycosylase, but not Kin17 protein, is translocated and differentially regulated by estrogens in rat brain cells. Neuroscience 136(1): 135-146

Carotti, A.; Stefanachi, A.; Raviña, E.; Sotelo, E.; Loza, M.Isabel.; Cadavid, M.Isabel.; Centeno, N.B.; Nicolotti, O. 2004: 8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B. European Journal of Medicinal Chemistry 39(10): 879-887

Ben Gaied, N.; Glasser, N.; Ramalanjaona, N.; Beltz, Hé.; Wolff, P.; Marquet, R.; Burger, A.; Mély, Y. 2005: 8-vinyl-deoxyadenosine, an alternative fluorescent nucleoside analog to 2'-deoxyribosyl-2-aminopurine with improved properties. Nucleic Acids Research 33(3): 1031-1039

Rosety-Rodriguez, M.; Ordonez, F.J.; Rosety, I.; Frias, L.; Rosety, M.A.; Rosety, J.M.; Rosety, M. 2006: 8-weeks training program attenuates mitochondrial oxidative stress in the liver of emotionally stressed rats. Histology and Histopathology 21(11): 1167-1170

Rossi, E.; de Gregori, M.; Grazia Patricelli, M.; Pramparo, T.; Argentiero, L.; Giglio, S.; Sosta, K.; Foresti, G.; Zuffardi, O. 2005: 8.5 Mb deletion at distal 5p in a male ascertained for azoospermia. American Journal of Medical Genetics. Part A 133a(2): 189-192

Gordon, B.C. 2005: 8000 years of caribou and human seasonal migration in the Canadian Barrenlands. Rangifer Special Issue 16: 155-162

Angiolillo, D.J.; Fernandez-Ortiz, A.; Bernardo, E.; Ramírez, C.; Escaned, J.; Moreno, R.; Hernández-Antolin, R.; Sabaté, M.; Trabetti, E.; Pignatti, P.Franco.; Macaya, C. 2004: 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 15(5): 427-433

Gkika, D.; Mahieu, F.; Nilius, B.; Hoenderop, J.G.J.; Bindels, Ré.J.M. 2004: 80K-H as a new Ca2+ sensor regulating the activity of the epithelial Ca2+ channel transient receptor potential cation channel V5 (TRPV5). Journal of Biological Chemistry 279(25): 26351-26357

Tong, Y.; Zhang, S.; Li, H.; Su, Z.; Kong, X.; Liu, H.; Xiao, C.; Sun, Y.; Shi, J.Jun. 2004: 8302A/C and (TTA)n polymorphisms in the HMG-CoA reductase gene may be associated with some plasma lipid metabolic phenotypes in patients with coronary heart disease. Lipids 39(3): 239-241

Algara-Suárez, P.; Espinosa-Tanguma, R. 2004: 8Br-cGMP mediates relaxation of tracheal smooth muscle through PKA. Biochemical and Biophysical Research Communications 314(2): 597-601

Bakker, R.A.; Weiner, D.M.; ter Laak, T.; Beuming, T.; Zuiderveld, O.P.; Edelbroek, M.; Hacksell, U.; Timmerman, H.; Brann, M.R.; Leurs, R. 2004: 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist. Molecular Pharmacology 65(3): 538-549

Anonymous 2004: 8th Corneal Conference, Cardiff University, Wales, UK, July 8-9, 2004. Ophthalmic Research 36(5): 284-297

Anonymous 2004: 8th European Magnesium Congress, Cluj-Napoca, Romania, may 25-28, 2004. Magnesium Research 17(3): 216-247

Anonymous 2004: 8th Leipzig Workshop: Predictive Medicine and the 1st International Workshop on Slide Based Cytometry (SBC), Leipzig, Germany, May 15-17, 2003. Cytometry 60A(2): 196-205

Anonymous 2003: 8th Nottingham International Breast Cancer Conference, Nottingham, UK, September 16-19, 2003. EJC Suppls 1(4): 1-47

Anonymous 2004: 8th Vienna International Workshop on Functional Electrical Stimulation, Vienna, Austria, September 10-13, 2004. Artificial Organs 28(8): 754-781

Sugimoto, R.; Kumagai, Y.; Nakai, Y.; Ishii, T. 2005: 9,10-Phenanthraquinone in diesel exhaust particles downregulates Cu,Zn-SOD and HO-1 in human pulmonary epithelial cells: intracellular iron scavenger 1,10-phenanthroline affords protection against apoptosis. Free Radical Biology and Medicine 38(3): 388-395

Shimada, H.; Oginuma, M.; Hara, A.; Imamura, Y. 2004: 9,10-phenanthrenequinone, a component of diesel exhaust particles, inhibits the reduction of 4-benzoylpyridine and all-trans-retinal and mediates superoxide formation through its redox cycling in pig heart. Chemical Research in Toxicology 17(8): 1145-1150

Kindler, H.L.; Avadhani, A.; Wade-Oliver, K.; Karrison, T.; Mani, S.; Vokes, E.E. 2004: 9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium. Investigational New Drugs 22(3): 323-327

Xu, J.; Drew, P.D. 2005: 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology 171(1-2): 135-144

Tantry, S., J.; Babu, V., V.S.resh 2003: 9-Fluorenylmethyl chloroformate (Fmoc-Cl) as a useful reagent for the synthesis of pentafluorophenyl, 2,4,5-trichlorophenyl, pentachlorophenyl, p-nitrophenyl, o-nitrophenyl and succinimidyl esters of N alpha-urethane protected amino acids. Letters in Peptide Science 10(5-6): 655-662

Choi, S.-E.; Sohn, S.; Cho, J.-W.; Shin, E.-A.; Song, P.-S.; Kang, Y. 2004: 9-Hydroxypheophorbide alpha-induced apoptotic death of MCF-7 breast cancer cells is mediated by c-Jun N-terminal kinase activation. Journal of Photochemistry and Photobiology. B Biology 73(1-2): 101-107

Calonghi, N.; Cappadone, C.; Pagnotta, E.; Farruggia, G.; Buontempo, F.; Boga, C.; Brusa, G.L.; Santucci, M.A.; Masotti, L. 2004: 9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells. Biochemical and Biophysical Research Communications 314(1): 138-142

Kniep, B.; Kniep, E.; Ozkucur, N.; Barz, S.; Bachmann, M.; Malisan, F.; Testi, R.; Rieber, E.Peter. 2006: 9-O-acetyl GD3 protects tumor cells from apoptosis. International Journal of Cancer 119(1): 67-73

Nomura, T.; Yasukata, T.; Narukawa, Y.; Uotani, K. 2005: 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens. Bioorganic and Medicinal Chemistry 13(21): 6054-6063

Fang, J.; Cao, Z.; Chen, Y.Charlie.; Reed, E.; Jiang, B-Hua. 2004: 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells. Molecular Pharmacology 66(1): 178-186

Shaish, A.; Harari, A.; Hananshvili, L.; Cohen, H.; Bitzur, R.; Luvish, T.; Ulman, E.; Golan, M.; Ben-Amotz, A.; Gavish, D.; Rotstein, Z.; Harats, D. 2006: 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients. Atherosclerosis 189(1): 215-221

Alvarez, R.; Vega, M.Jesús.; Kammerer, S.; Rossin, Aélie.; Germain, P.; Gronemeyer, H.; de Lera, A.R. 2004: 9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorganic and Medicinal Chemistry Letters 14(24): 6117-6122

Chuang, K-Hsiang.; Lee, Y-Fen.; Lin, W-Jye.; Chu, C-Yi.; Altuwaijri, S.; Wan, Y-Jui.Yvonne.; Chang, C. 2005: 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor. Molecular Endocrinology 19(5): 1200-1212

Haberkorn, Vérie.; Oziol, L.; Goudonnet, Hé. 2003: 9-cis-retinoic acid regulation of four UGT isoforms in hepatocytes from rats with various thyroid states. Pharmaceutical Research 20(10): 1568-1573

Singh, R.R.; Gururaj, A.E.; Vadlamudi, R.K.; Kumar, R. 2006: 9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway. Journal of Biological Chemistry 281(22): 15394-15404

Stauffer, K.J.; Williams, P.D.; Selnick, H.G.; Nantermet, P.G.; Newton, C.L.; Homnick, C.F.; Zrada, M.M.; Lewis, S.Dale.; Lucas, B.J.; Krueger, J.A.; Pietrak, B.L.; Lyle, E.A.; Singh, R.; Miller-Stein, C.; White, R.B.; Wong, B.; Wallace, A.A.; Sitko, G.R.; Cook, J.J.; Holahan, M.A.; Stranieri-Michener, M.; Leonard, Y.M.; Lynch, J.J.; McMasters, D.R.; Yan, Y. 2005: 9-hydroxyazafluorenes and their use in thrombin inhibitors. Journal of Medicinal Chemistry 48(7): 2282-2293

Calonghi, N.; Pagnotta, E.; Parolin, C.; Tognoli, C.; Boga, C.; Masotti, L. 2006: 9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma. Biochemical and Biophysical Research Communications 342(2): 585-588

Li-Jun-Chan; Sha-Xian-Yi; Zhang-Li-Jun; Fang-Xiao-Ling 2005: 9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo. Yaoxue Xuebao 40(11): 970-975

Ouyang, W.; Ma, D.; Lin, D.; Sun, Y.; Liu, X.; Li, Q.; Jia, W.; Cao, Y.; Zhu, Y.; Jin, B. 2003: 9.1C3 is identical to LAIR-1, which is expressed on hematopoietic progenitors. Biochemical and Biophysical Research Communications 310(4): 1236-1240

Kumarathasan, P.; Blais, E.; Goegan, P.; Yagminas, A.; Guénette, J.; Adamson, I.Y.R.; Crapo, J.D.; Mason, R.J.; Vincent, R. 2005: 90-day repeated inhalation exposure of surfactant Protein-C/tumor necrosis factor-alpha, (SP-C/TNF-alpha) transgenic mice to air pollutants. International Journal of Toxicology 24(1): 59-67

Hu, Y.; Fang, X.; Dunham, S.M.; Prada, C.; Stachowiak, E.K.; Stachowiak, M.K. 2004: 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling. Journal of Biological Chemistry 279(28): 29325-29335

Heiri, O.; Lotter, A., F. 2003: 9000 years of chironomid assemblage dynamics in an Alpine lake: Long-term trends, sensitivity to disturbance, and resilience of the fauna. Journal of Paleolimnology 30(3): 273-289

Koinig, K.A.; Shotyk, W.; Lotter, A.F.; Ohlendorf, C.; Sturm, M. 2003: 9000 years of geochemical evolution of lithogenic major and trace elements in the sediment of an alpine lake: The role of climate, vegetation, and land-use history. Journal of Paleolimnology 30(3): 307-320

Butler Virginia L.; O. Connor Jim E. 2004: 9000 years of salmon fishing on the Columbia River, North America. Quaternary Research 62(1): 1-8

Haarala, C.; Ek, M.; Björnberg, L.; Laine, M.; Revonsuo, A.; Koivisto, M.; Hämäläinen, H. 2004: 902 MHz mobile phone does not affect short term memory in humans. Bioelectromagnetics 25(6): 452-456

Cober, E., R.; Bing, D.; Voldeng, H., D.; Soper, J.; Guillemette, R., J.D.; Sloan, A.; Hedges, B., R. 2006: 90A01 soybean. Canadian Journal of Plant Science 86(2): 481-482

Grassadonia, A.; Tinari, N.; Iurisci, I.; Piccolo, E.; Cumashi, A.; Innominato, P.; D'Egidio, M.; Natoli, C.; Piantelli, M.; Iacobelli, S. 2004: 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconjugate Journal 19(7-9): 551-556

Bair, E.L.; Nagle, R.B.; Ulmer, T.A.; Laferté, S.; Bowden, G.Tim. 2005: 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression. Prostate 66(3): 283-293

Koller, J. 2005: 90th birthday of Professor Rudolf Klen, MD, DSc. Cell and Tissue Banking 6(2): 161-162

Belyaev, I.Y.; Hillert, L.; Protopopova, M.; Tamm, C.; Malmgren, L.O.G.; Persson, B.R.R.; Selivanova, G.; Harms-Ringdahl, M. 2005: 915 MHz microwaves and 50 Hz magnetic field affect chromatin conformation and 53BP1 foci in human lymphocytes from hypersensitive and healthy persons. Bioelectromagnetics 26(3): 173-184

Stronati, L.; Testa, A.; Moquet, J.; Edwards, A.; Cordelli, E.; Villani, P.; Marino, C.; Fresegna, A.M.; Appolloni, M.; Lloyd, D. 2006: 935 MHz cellular phone radiation. An in vitro study of genotoxicity in human lymphocytes. International Journal of Radiation Biology 82(5): 339-346

Venn, R.F.; Merson, J.; Cole, S.; Macrae, P. 2005: 96-Well solid-phase extraction: a brief history of its development. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 817(1): 77-80

Johnson, M.; Grinsztejn, B.; Rodriguez, C.; Coco, J.; DeJesus, E.; Lazzarin, A.; Lichtenstein, K.; Wirtz, V.; Rightmire, A.; Odeshoo, L.; McLaren, C. 2006: 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures. Aids 20(5): 711-718

Cheng, Z.; Mahmood, A.; Li, H.; Davison, A.; Jones, A.G. 2005: 99mTcOAADT]-(CH2)2-NEt2: a potential small-molecule single-photon emission computed tomography probe for imaging metastatic melanoma. Cancer Research 65(12): 4979-4986

Sükan, A.; Yapar, Z.; SAhin, B.; Kara, O.; Fuat Yapar, A.; CEtiner, S.; Kibar, M. 2004: 99MTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response. Nuclear Medicine Communications 25(8): 777-785

Turhal, N.S.; Dane, F.; Dede, F.; Gumus, M.; Yumuk, P.Fulden.; Cakalagaoglu, F.; Savci, D.; Karaman, M.; Gulluoglu, B.; Turoglu, H.Turgut. 2004: 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis. Anticancer Research 24(3b): 1999-2006

Van Den Bossche, B.; D'haeninck, E.; De Winter, F.; Van Belle, S.; Dierckx, R.A.; Van De Wiele, C. 2004: 99mTC depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer. Nuclear Medicine Communications 25(8): 787-792

Nigri, F.; Bernardo Filho, M.; Telles, C.; Silva, J.W.E.; Boasquevisque, E.M. 2004: 99mTC-DTPA ventriculocisternography for postoperative evaluation of endoscopic third ventriculostomy: A preliminary study model. Biomedical Research 15(2): 138-141

Kim, S.Hoon.; Chung, S.Kyo.; Bahk, Y-Whee.; Chung, Y.An.; Song, K.Sub. 2003: 99mTc-HDP pinhole SPECT findings of foot reflex sympathetic dystrophy: radiographic and MRI correlation and a speculation about subperiosteal bone resorption. Journal of Korean Medical Science 18(5): 707-714

Gardner, A.; Pagani, M.; Beier, H.; Jacobsson, H.; Larsson, S.A.; Hällström, T. 2004: 99mTc-HMPAO distribution at SPECT is associated with succinate-cytochrome c reductase (SCR) activity in subjects with psychiatric disorders. Nuclear Medicine and Biology 31(2): 277-282

Kothari, K.K.; Satpati, D.; Joshi, S.; Venkatesh, M.; Ramamoorthy, N.; Pillai, M.R.A. 2005: 99mTc carbonyl t-butyl isonitrile: A potential new agent for myocardial perfusion imaging. Nuclear Medicine Communications 26(2): 155-161

Gemmel, F.; De Winter, F.; Van Laere, K.; Vogelaers, D.; Uyttendaele, D.; Dierckx, R.A. 2004: 99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nuclear Medicine Communications 25(3): 277-283

Atasever, T.; Ozkaya, O.; Abamor, E.; Söylemezoğlu, Oğuz.; Buyan, N.; Unlü, M. 2004: 99mTc ethylene dicysteine scintigraphy for diagnosing cortical defects in acute pyelonephritis: a comparative study with 99mTc dimercaptosuccinic acid. Nuclear Medicine Communications 25(9): 967-970

Liu, Z.; Stevenson, G.D.; Barrett, H.H.; Kastis, G.A.; Bettan, M.; Furenlid, L.R.; Wilson, D.W.; Woolfenden, J.M.; Pak, K.Yan. 2004: 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Nuclear Medicine Communications 25(7): 711-720

Wunderlich, G.; Grüning, T.; Paulke, B.R.; Lieske, A.; Kotzerke, Jörg. 2004: 99mTc labelled model drug carriers - labeling, stability and organ distribution in rats. Nuclear Medicine and Biology 31(1): 87-92

Parisella, M.; D'Alessandria, C.; van de Bossche, B.; Chianelli, M.; Ronga, G.; Papini, E.; Mikolajczak, R.; Letizia, C.; De Toma, G.; Veneziani, A.; Scopinaro, F.; Signore, A. 2004: 99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biotherapy and Radiopharmaceuticals 19(2): 211-217

Wilczek, B.; Svensson, L.; Danielsson, R.; Celebiouglu, F.; Larsson, S.A.; Jacobsson, H. 2004: 99mTc-exametazime as a breast tumor-seeking agent: comparison with 99mTc-sestamibi. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(12): 2040-2044

Pelosi, E.; Baiocco, C.; Pennone, M.; Migliaretti, G.; Varetto, T.; Maiello, A.; Bellò, M.; Bisi, G. 2004: 99mTc-HMPAO-leukocyte scintigraphy in patients with symptomatic total hip or knee arthroplasty: improved diagnostic accuracy by means of semiquantitative evaluation. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(3): 438-444

Vermeersch, H.; Loose, D.; Lahorte, C.; Mervillie, K.; Dierckx, R.; Steinmetz, N.; Vanderheyden, J-Luc.; Cuvelier, C.; Slegers, G.; Van de Wiele, C. 2004: 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma. Nuclear Medicine Communications 25(3): 259-263

Signore, A.; Annovazzi, A.; Barone, R.; Bonanno, E.; D'Alessandria, C.; Chianelli, M.; Mather, S.J.; Bottoni, U.; Panetta, C.; Innocenzi, D.; Scopinaro, F.; Calvieri, S. 2004: 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(10): 1647-1652

Taylor, A.T.; Lipowska, M.; Hansen, L.; Malveaux, E.; Marzilli, L.G. 2004: 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(5): 885-891